Section 11

EurekaMag PDF full texts Chapter 10,777


Norman, J.T.; Orphanides, C.; Garcia, P.; Fine, L.G. 1999: Hypoxia-induced changes in extracellular matrix metabolism in renal cells. Experimental Nephrology 7(5-6): 463-469
Sanidas, D.; Garnham, A.; Mian, R. 2002: Hypoxia-induced chemiluminescence in human leukocytes: The role of Ca2+. European Journal of Pharmacology 453(2-3): 183-187
Todor, A.; Sharov, V.G.; Tanhehco, E.J.; Silverman, N.; Bernabei, A.; Sabbah, H.N. 2002: Hypoxia-induced cleavage of caspase-3 and DFF45/ICAD in human failed cardiomyocytes. American Journal of Physiology. Heart and Circulatory Physiology 283(3): H990-H995
Jögi, A.; Øra, I.; Nilsson, H.; Poellinger, L.; Axelson, Håkan.; Påhlman, S. 2003: Hypoxia-induced dedifferentiation in neuroblastoma cells. Cancer Letters 197(1-2): 145-150
Xu, L.; Xie, K.; Mukaida, N.; Matsushima, K.; Fidler, I.J. 1999: Hypoxia-induced elevation in interleukin-8 expression by human ovarian carcinoma cells. Cancer Research 59(22): 5822-5829
Dada, L.A.; Chandel, N.S.; Ridge, K.M.; Pedemonte, C.; Bertorello, A.M.; Sznajder, J.I. 2003: Hypoxia-induced endocytosis of Na,K-ATPase in alveolar epithelial cells is mediated by mitochondrial reactive oxygen species and PKC-zeta. Journal of Clinical Investigation 111(7): 1057-1064
Matsushita, H.; Morishita, R.; Nata, T.; Aoki, M.; Nakagami, H.; Taniyama, Y.; Yamamoto, K.; Higaki, J.; Yasufumi, K.; Ogihara, T. 2000: Hypoxia-induced endothelial apoptosis through nuclear factor-kappaB (NF-kappaB)-mediated bcl-2 suppression: in vivo evidence of the importance of NF-kappaB in endothelial cell regulation. Circulation Research 86(9): 974-981
Kondo, A.; Safaei, R.; Mishima, M.; Niedner, H.; Lin, X.; Howell, S.B. 2001: Hypoxia-induced enrichment and mutagenesis of cells that have lost DNA mismatch repair. Cancer Research 61(20): 7603-7607
Tohgi, H.; Utsugisawa, K.; Nagane, Y. 2000: Hypoxia-induced expression of C1q, a subcomponent of the complement system, in cultured rat PC12 cells. Neuroscience Letters 291(3): 151-154
Burke, B.; Giannoudis, A.; Corke, K.P.; Gill, D.; Wells, M.; Ziegler-Heitbrock, L.; Lewis, C.E. 2003: Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy. American Journal of Pathology 163(4): 1233-1243
Park, S-Ki.; Dadak, A.M.; Haase, V.H.; Fontana, L.; Giaccia, A.J.; Johnson, R.S. 2003: Hypoxia-induced gene expression occurs solely through the action of hypoxia-inducible factor 1alpha (HIF-1alpha): role of cytoplasmic trapping of HIF-2alpha. Molecular and Cellular Biology 23(14): 4959-4971
Fischer, S.; Wobben, M.; Marti, H.H.; Renz, D.; Schaper, W. 2002: Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1. Microvascular Research 63(1): 70-80
Burgman, P.; Odonoghue, J.A.; Humm, J.L.; Ling, C.C. 2001: Hypoxia-Induced increase in FDG uptake in MCF7 cells. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 42(1): 170-175
Berna, N.; Arnould, T.; Remacle, J.; Michiels, C. 2001: Hypoxia-induced increase in intracellular calcium concentration in endothelial cells: role of the Na(+)-glucose cotransporter. Journal of Cellular Biochemistry 84(1): 115-131
Kan, C.; Abe, M.; Yamanaka, M.; Ishikawa, O. 2003: Hypoxia-induced increase of matrix metalloproteinase-1 synthesis is not restored by reoxygenation in a three-dimensional culture of human dermal fibroblasts. Journal of Dermatological Science 32(1): 75-82
Saed, G.M.; Diamond, M.P. 2002: Hypoxia-induced irreversible up-regulation of type I collagen and transforming growth factor-beta1 in human peritoneal fibroblasts. Fertility and Sterility 78(1): 144-147
Rauchová, H.; Koudelová, J.; Drahota, Zĕk.; Mourek, J. 2002: Hypoxia-induced lipid peroxidation in rat brain and protective effect of carnitine and phosphocreatine. Neurochemical Research 27(9): 899-904
Ghribi, O.; Lapierre, L.; Girard, M.; Ohayon, M.; Nalbantoglu, J.; Massicotte, G. 1999: Hypoxia-induced loss of synaptic transmission is exacerbated in hippocampal slices of transgenic mice expressing C-terminal fragments of Alzheimer amyloid precursor protein. Hippocampus 9(3): 201-205
Cooper, R.U.; Clough, L.M.; Farwell, M.A.; West, T.L. 2002: Hypoxia-induced metabolic and antioxidant enzymatic activities in the estuarine fish Leiostomus xanthurus. Journal of Experimental: 1-20
Englander, E.W.; Greeley, G.H.; Wang, G.; Perez-Polo, J.R.; Lee, H.M. 1999: Hypoxia-induced mitochondrial and nuclear DNA damage in the rat brain. Journal of Neuroscience Research 58(2): 262-269
Mishra, O.P.; Akhter, W.; Ashraf, Q.M.; Delivoria-Papadopoulos, M. 2003: Hypoxia-induced modification of poly (ADP-ribose) polymerase and dna polymerase beta activity in cerebral cortical nuclei of newborn piglets: role of nitric oxide. Neuroscience 119(4): 1023-1032
Mishra, O.P.; Qayyum, I.; Delivoria-Papadopoulos, M. 2003: Hypoxia-induced modification of the inositol triphosphate receptor in neuronal nuclei of newborn piglets: role of nitric oxide. Journal of Neuroscience Research 74(2): 333-338
Mastyugin, V.; Aversa, E.; Bonazzi, A.; Vafaes, C.; Mieyal, P.; Schwartzman, M.L. 1999: Hypoxia-induced production of 12-hydroxyeicosanoids in the corneal epithelium: involvement of a cytochrome P-4504B1 isoform. Journal of Pharmacology and Experimental Therapeutics 289(3): 1611-1619
Das, M.; Bouchey, D.M.; Moore, M.J.; Hopkins, D.C.; Nemenoff, R.A.; Stenmark, K.R. 2001: Hypoxia-induced proliferative response of vascular adventitial fibroblasts is dependent on g protein-mediated activation of mitogen-activated protein kinases. Journal of Biological Chemistry 276(19): 15631-15640
Hanaoka, M.; Tanaka, M.; Ge, R.L.; Droma, Y.; Ito, A.; Miyahara, T.; Koizumi, T.; Fujimoto, K.; Fujii, T.; Kobayashi, T.; Kubo, K. 2000: Hypoxia-induced pulmonary blood redistribution in subjects with a history of high-altitude pulmonary edema. Circulation 101(12): 1418-1422
Voelkel, N.F.; Tuder, R.M. 2000: Hypoxia-induced pulmonary vascular remodeling: a model for what human disease?. Journal of Clinical Investigation 106(6): 733-738
Seta, K.A.; Kim, R.; Kim, H.W.; Millhorn, D.E.; Beitner-Johnson, D. 2001: Hypoxia-induced regulation of MAPK phosphatase-1 as identified by subtractive suppression hybridization and cDNA microarray analysis. Journal of Biological Chemistry 276(48): 44405-44412
Ambalavanan, N.; Bulger, A.; Philips III, J.B. 1999: Hypoxia-induced release of peptide growth factors from neonatal porcine pulmonary artery smooth muscle cells. Biology of the Neonate 76(5): 311-319
Inoue, T.; Haque, Z.; Lukowiak, K.; Syed, N.I. 2001: Hypoxia-induced respiratory patterned activity in Lymnaea originates at the periphery. Journal of Neurophysiology 86(1): 156-163
Fu, X.W.; Nurse, C.A.; Wong, V.; Cutz, E. 2002: Hypoxia-induced secretion of serotonin from intact pulmonary neuroepithelial bodies in neonatal rabbit. Journal of Physiology 539(Pt 2): 503-510
Bickler, P.E.; Donohoe, P.H.; Buck, L.T. 2000: Hypoxia-induced silencing of NMDA receptors in turtle neurons. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 20(10): 3522-3528
Prass, K.; Scharff, A.; Ruscher, K.; Löwl, D.; Muselmann, C.; Victorov, I.; Kapinya, K.; Dirnagl, U.; Meisel, A. 2003: Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoietin. Stroke 34(8): 1981-1986
Razeghi, P.; Essop, M.Faadiel.; Huss, J.M.; Abbasi, S.; Manga, N.; Taegtmeyer, H. 2003: Hypoxia-induced switches of myosin heavy chain iso-gene expression in rat heart. Biochemical and Biophysical Research Communications 303(4): 1024-1027
D'Angelo, G.; Ladoux, A.; Frelin, C. 2000: Hypoxia-induced transcriptional activation of vascular endothelial growth factor is inhibited by serum. Biochemical and Biophysical Research Communications 267(1): 334-338
Rofstad, E.K.; Sundfør, K.; Lyng, H.; Tropé, C.G. 2000: Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis. British Journal of Cancer 83(3): 354-359
Hartmann, A.; Kunz, M.; Köstlin, S.; Gillitzer, R.; Toksoy, A.; Bröcker, E.B.; Klein, C.E. 1999: Hypoxia-induced up-regulation of angiogenin in human malignant melanoma. Cancer Research 59(7): 1578-1583
Hoffmann, A.; Gloe, T.; Pohl, U. 2001: Hypoxia-induced upregulation of eNOS gene expression is redox-sensitive: a comparison between hypoxia and inhibitors of cell metabolism. Journal of Cellular Physiology 188(1): 33-44
Naughton, D.P. 2003: Hypoxia-induced upregulation of the glycolytic enzyme glucose-6-phosphate isomerase perpetuates rheumatoid arthritis. Medical Hypotheses 60(3): 332-334
Schoch, H.J.; Fischer, S.; Marti, H.H. 2002: Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain. Brain: a Journal of Neurology 125(Pt 11): 2549-2557
Marti, H.J.; Bernaudin, M.; Bellail, A.; Schoch, H.; Euler, M.; Petit, E.; Risau, W. 2000: Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. American Journal of Pathology 156(3): 965-976
Mandriota, S.J.; Pyke, C.; Di Sanza, C.; Quinodoz, P.; Pittet, B.; Pepper, M.S. 2000: Hypoxia-inducible angiopoietin-2 expression is mimicked by iodonium compounds and occurs in the rat brain and skin in response to systemic hypoxia and tissue ischemia. American Journal of Pathology 156(6): 2077-2089
Stolze, I.; Berchner-Pfannschmidt, U.; Freitag, P.; Wotzlaw, C.; Rössler, J.; Frede, S.; Acker, H.; Fandrey, J. 2002: Hypoxia-inducible erythropoietin gene expression in human neuroblastoma cells. Blood 100(7): 2623-2628
Acs, G.; Zhang, P.J.; McGrath, C.M.; Acs, P.; McBroom, J.; Mohyeldin, A.; Liu, S.; Lu, H.; Verma, A. 2003: Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression. American Journal of Pathology 162(6): 1789-1806
Hewitson, K.S.; McNeill, L.A.; Riordan, M.V.; Tian, Y.-M.; Bullock, A.N.; Welford, R.W.; Elkins, J.M.; Oldham, N.J.; Bhattacharya, S.; Gleadle, J.M.; Ratcliffe, P.J.; Pugh, C.W.; Schofield, C.J. 2002: Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. Journal of Biological Chemistry 277(29): 26351-26355
Volm, M.; Koomägi, R. 2000: Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer. Anticancer Research 20(3a): 1527-1533
Koukourakis, M.I.; Giatromanolaki, A.; Sivridis, E.; Simopoulos, C.; Turley, H.; Talks, K.; Gatter, K.C.; Harris, A.L. 2002: Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer. International Journal of Radiation Oncology Biology Physics 53(5): 1192-1202
Lu, H.; Forbes, R.A.; Verma, A. 2002: Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. Journal of Biological Chemistry 277(26): 23111-23115
H.R.icheng; Dai Aiguo; Tan Shuangxiang 2002: Hypoxia-inducible factor 1 alpha upregulates the expression of inducible nitric oxide synthase gene in pulmonary arteries of hypoxic rat. Chinese Medical Journal (English Edition) 115(12): 1833-1837
Grosfeld, A.; Andre, J.; Hauguel-De Mouzon, S.; Berra, E.; Pouyssegur, J.; Guerre-Millo, M. 2002: Hypoxia-inducible factor 1 transactivates the human leptin gene promoter. Journal of Biological Chemistry 277(45): 42953-42957
Furuta, G.T.; Turner, J.R.; Taylor, C.T.; Hershberg, R.M.; Comerford, K.; Narravula, S.; Podolsky, D.K.; Colgan, S.P. 2001: Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia. Journal of Experimental Medicine 193(9): 1027-1034
Semenza, G.L. 2001: Hypoxia-inducible factor 1: control of oxygen homeostasis in health and disease. Pediatric Research 49(5): 614-617
Semenza, G.L. 2001: Hypoxia-inducible factor 1: Oxygen homeostasis and disease pathophysiology. Trends in Molecular Medicine 7(8): 345-350
Zhong, H.; Hanrahan, C.; van der Poel, H.; Simons, J.W. 2001: Hypoxia-inducible factor 1alpha and 1beta proteins share common signaling pathways in human prostate cancer cells. Biochemical and Biophysical Research Communications 284(2): 352-356
Sutter, C.H.; Laughner, E.; Semenza, G.L. 2000: Hypoxia-inducible factor 1alpha protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations. Proceedings of the National Academy of Sciences of the United States of America 97(9): 4748-4753
Yuan, Y.; Beitner-Johnson, D.; Millhorn, D.E. 2001: Hypoxia-inducible factor 2alpha binds to cobalt in vitro. Biochemical and Biophysical Research Communications 288(4): 849-854
Huang, L.Eric.; Bunn, H.Franklin. 2003: Hypoxia-inducible factor and its biomedical relevance. Journal of Biological Chemistry 278(22): 19575-19578
Ramírez-Bergeron, D.L.; Simon, M.C. 2001: Hypoxia-inducible factor and the development of stem cells of the cardiovascular system. Stem Cells 19(4): 279-286
McNeill, L.A.; Hewitson, K.S.; Claridge, T.D.; Seibel, Jürgen.F.; Horsfall, L.E.; Schofield, C.J. 2002: Hypoxia-inducible factor asparaginyl hydroxylase (FIH-1) catalyses hydroxylation at the beta-carbon of asparagine-803. Biochemical Journal 367(Pt 3): 571-575
Garayoa, M.; Martínez, A.; Lee, S.; Pío, R.; An, W.G.; Neckers, L.; Trepel, J.; Montuenga, L.M.; Ryan, H.; Johnson, R.; Gassmann, M.; Cuttitta, F. 2000: Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: a possible promotion mechanism of carcinogenesis. Molecular Endocrinology 14(6): 848-862
Hierholzer, C.; Harbrecht, B.G.; Billiar, T.R.; Tweardy, D.J. 2001: Hypoxia-inducible factor-1 activation and cyclo-oxygenase-2 induction are early reperfusion-independent inflammatory events in hemorrhagic shock. Archives of Orthopaedic and Trauma Surgery 121(4): 219-222
Yamakawa, M.; Liu, L.X.; Date, T.; Belanger, A.J.; Vincent, K.A.; Akita, G.Y.; Kuriyama, T.; Cheng, S.H.; Gregory, R.J.; Jiang, C. 2003: Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors. Circulation Research 93(7): 664-673
Caniggia, I.; Mostachfi, H.; Winter, J.; Gassmann, M.; Lye, S.J.; Kuliszewski, M.; Post, M. 2000: Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFbeta(3). Journal of Clinical Investigation 105(5): 577-587
Comerford, K.M.; Wallace, T.J.; Karhausen, Jörn.; Louis, N.A.; Montalto, M.C.; Colgan, S.P. 2002: Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Research 62(12): 3387-3394
Minchenko, A.; Leshchinsky, I.; Opentanova, I.; Sang, N.; Srinivas, V.; Armstead, V.; Caro, J. 2001: Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) gene. Its possible role in the Warburg effect. Journal of Biological Chemistry 277(8): 6183-6187
Jiang, Y.; Wu, J.; Keep, R.F.; Hua, Y.; Hoff, J.T.; Xi, G. 2002: Hypoxia-inducible factor-1alpha accumulation in the brain after experimental intracerebral hemorrhage. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 22(6): 689-696
Takahashi, R.; Tanaka, S.; Hiyama, T.; Ito, M.; Kitadai, Y.; Sumii, M.; Haruma, K.; Chayama, K. 2003: Hypoxia-inducible factor-1alpha expression and angiogenesis in gastrointestinal stromal tumor of the stomach. Oncology Reports 10(4): 797-802
Iida, T.; Mine, S.; Fujimoto, H.; Suzuki, K.; Minami, Y.; Tanaka, Y. 2002: Hypoxia-inducible factor-1alpha induces cell cycle arrest of endothelial cells. Genes to Cells: Devoted to Molecular and Cellular Mechanisms 7(2): 143-149
Ryan, H.E.; Poloni, M.; McNulty, W.; Elson, D.; Gassmann, M.; Arbeit, J.M.; Johnson, R.S. 2000: Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. Cancer Research 60(15): 4010-4015
Vukovic, V.; Haugland, H.K.; Nicklee, T.; Morrison, A.J.; Hedley, D.W. 2001: Hypoxia-inducible factor-1alpha is an intrinsic marker for hypoxia in cervical cancer xenografts. Cancer Research 61(20): 7394-7398
Lang, K.J.D.; Kappel, A.; Goodall, G.J. 2002: Hypoxia-inducible factor-1alpha mRNA contains an internal ribosome entry site that allows efficient translation during normoxia and hypoxia. Molecular Biology of the Cell 13(5): 1792-1801
Halterman, M.W.; Miller, C.C.; Federoff, H.J. 1999: Hypoxia-inducible factor-1alpha mediates hypoxia-induced delayed neuronal death that involves p53. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 19(16): 6818-6824
Kuwahara, F.; Kai, H.; Tokuda, K.; Shibata, R.; Kusaba, K.; Tahara, N.; Niiyama, H.; Nagata, T.; Imaizumi, T. 2002: Hypoxia-inducible factor-1alpha/vascular endothelial growth factor pathway for adventitial vasa vasorum formation in hypertensive rat aorta. Hypertension 39(1): 46-50
Brusselmans, K.; Bono, F.; Maxwell, P.; Dor, Y.; Dewerchin, M.; Collen, D.; Herbert, J.M.; Carmeliet, P. 2001: Hypoxia-inducible factor-2alpha (HIF-2alpha) is involved in the apoptotic response to hypoglycemia but not to hypoxia. Journal of Biological Chemistry 276(42): 39192-39196
Blagosklonny, M.V. 2001: Hypoxia-inducible factor: Achilles' heel of antiangiogenic cancer therapy (review). International Journal of Oncology 19(2): 257-262
Beasley, N.J.P.; Leek, R.; Alam, M.; Turley, H.; Cox, G.J.; Gatter, K.; Millard, P.; Fuggle, S.; Harris, A.L. 2002: Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients. Cancer Research 62(9): 2493-2497
Freeburg, P.B.; Abrahamson, D.R. 2003: Hypoxia-inducible factors and kidney vascular development. Journal of the American Society of Nephrology: Jasn 14(11): 2723-2730
Tao, F.; Zhang, L.M.; Sun, F.Y. 1999: Hypoxia-ischemia altered expression of glutamate transporter EAAT1 in neonatal rat brain. Zhongguo Yao Li Xue Bao 20(2): 107-111
Tan, S.; Bose, R.; Derrick, M. 2001: Hypoxia-ischemia in fetal rabbit brain increases reactive nitrogen species production: Quantitative estimation of nitrotyrosine. Free Radical Biology and Medicine 30(9): 1045-1051
Gurd, J.W.; Bissoon, N.; Nguyen, T.H.; Lombroso, P.J.; Rider, C.C.; Beesley, P.W.; Vannucci, S.J. 1999: Hypoxia-ischemia in perinatal rat brain induces the formation of a low molecular weight isoform of striatal enriched tyrosine phosphatase (STEP). Journal of Neurochemistry 73(5): 1990-1994
Hattori, I.; Takagi, Y.; Nozaki, K.; Kondo, N.; Bai, J.; Nakamura, H.; Hashimoto, N.; Yodoi, J. 2002: Hypoxia-ischemia induces thioredoxin expression and nitrotyrosine formation in new-born rat brain. Redox Report: Communications in Free Radical Research 7(5): 256-259
Clawson, T.F.; Vannucci, S.J.; Wang, G.M.; Seaman, L.B.; Yang, X.L.; Lee, W.H. 1999: Hypoxia-ischemia-induced apoptotic cell death correlates with IGF-i mRNA decrease in neonatal rat brain. Biological Signals and Receptors 8(4-5): 281-293
Lassmann, H. 2003: Hypoxia-like tissue injury as a component of multiple sclerosis lesions. Journal of the Neurological Sciences 206(2): 187-191
Gee, M.S.; Koch, C.J.; Evans, S.M.; Jenkins, W.T.; Pletcher, C.H.; Moore, J.S.; Koblish, H.K.; Lee, J.; Lord, E.M.; Trinchieri, G.; Lee, W.M. 1999: Hypoxia-mediated apoptosis from angiogenesis inhibition underlies tumor control by recombinant interleukin 12. Cancer Research 59(19): 4882-4889
Graham, C.H.; Forsdike, J.; Fitzgerald, C.J.; Macdonald-Goodfellow, S. 1999: Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression. International Journal of Cancer 80(4): 617-623
Delerive, P.; Oudot, F.; Ponsard, B.; Talpin, S.; Sergiel, J.P.; Cordelet, C.; Athias, P.; Grynberg, A. 1999: Hypoxia-reoxygenation and polyunsaturated fatty acids modulate adrenergic functions in cultured cardiomyocytes. Journal of Molecular and Cellular Cardiology 31(2): 377-386
Zou, M.H.; Bachschmid, M. 1999: Hypoxia-reoxygenation triggers coronary vasospasm in isolated bovine coronary arteries via tyrosine nitration of prostacyclin synthase. Journal of Experimental Medicine 190(1): 135-139
Yang, B.C.; Zander, D.S.; Mehta, J.L. 1999: Hypoxia-reoxygenation-induced apoptosis in cultured adult rat myocytes and the protective effect of platelets and transforming growth factor-beta(1). Journal of Pharmacology and Experimental Therapeutics 291(2): 733-738
Hung, T-Ho.; Skepper, J.N.; Charnock-Jones, D.Stephen.; Burton, G.J. 2002: Hypoxia-reoxygenation: A potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia. Circulation Research 90(12): 1274-1281
Tercel, M.; Lee, A.E.; Hogg, A.; Anderson, R.F.; Lee, H.H.; Siim, B.G.; Denny, W.A.; Wilson, W.R. 2001: Hypoxia-selective antitumor agents. 16. Nitroarylmethyl quaternary salts as bioreductive prodrugs of the alkylating agent mechlorethamine. Journal of Medicinal Chemistry 44(21): 3511-3522
Shyam, K.; Penketh, P.G.; Shapiro, M.; Belcourt, M.F.; Loomis, R.H.; Rockwell, S.; Sartorelli, A.C. 1999: Hypoxia-selective nitrobenzyloxycarbonyl derivatives of 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazines. Journal of Medicinal Chemistry 42(5): 941-946
Park, J.H.; Okayama, N.; Gute, D.; Krsmanovic, A.; Battarbee, H.; Alexander, J.S. 1999: Hypoxia/aglycemia increases endothelial permeability: role of second messengers and cytoskeleton. American Journal of Physiology 277(6): C1066-C1074
de Paula Brotto, M.; van Leyen, S.A.; Brotto, L.S.; Jin, J.P.; Nosek, C.M.; Nosek, T.M. 2001: Hypoxia/fatigue-induced degradation of troponin I and troponin C: New insights into physiologic muscle fatigue. Pflugers Archiv: European Journal of Physiology 442(5): 738-744
Johns, L.; Sinclair, A.J.; Davies, J.A. 2000: Hypoxia/hypoglycemia-induced amino acid release is decreased in vitro by preconditioning. Biochemical and Biophysical Research Communications 276(1): 134-136
Dong-Gaoxiang; Feng-Yipu 1999: Hypoxia/hypoglycemia-induced apoptosis of rat cortical neurons is prevented by dl-3-butylphthalide. Yaoxue Xuebao 34(3): 176-180
Yan, S.F.; Mackman, N.; Kisiel, W.; Stern, D.M.; Pinsky, D.J. 1999: Hypoxia/Hypoxemia-Induced activation of the procoagulant pathways and the pathogenesis of ischemia-associated thrombosis. Arteriosclerosis Thrombosis and Vascular Biology 19(9): 2029-2035
Huang, K.P.; Huang, F.L.; Chen, H.C. 1999: Hypoxia/ischemia induces dephosphorylation of rat brain neuromodulin/GAP-43 in vivo. Journal of Neurochemistry 72(3): 1294-1306
Kaul, D.K.; Hebbel, R.P. 2000: Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice. Journal of Clinical Investigation 106(3): 411-420
Wang, J-Yu.; Shum, A.Y-C.; Wang, J-Yi. 2002: Hypoxia/reoxygenation induces cell injury via different mechanisms in cultured rat cortical neurons and glial cells. Neuroscience Letters 322(3): 187-191
Kunz, M.; Bloss, G.; Gillitzer, R.; Gross, G.; Goebeler, M.; Rapp, U.R.; Ludwig, S. 2002: Hypoxia/reoxygenation induction of monocyte chemoattractant protein-1 in melanoma cells: involvement of nuclear factor-kappaB, stimulatory protein-1 transcription factors and mitogen-activated protein kinase pathways. Biochemical Journal 366(Part 1): 299-306
Hu, Q.; Ziegelstein, R.C. 2000: Hypoxia/reoxygenation stimulates intracellular calcium oscillations in human aortic endothelial cells. Circulation 102(20): 2541-2547
Makarov, P.Romanovich.; Wiswedel, I.; Augustin, W.; Schild, L. 2002: Hypoxia/reoxygenation-induced damage to mitochondrial activity is determined by glutathione threshold in astroglia-rich cell cultures. Brain Research 933(2): 91-97
Wu, R.S.S. 2002: Hypoxia: From molecular responses to ecosystem responses. Marine Pollution Bulletin 45(1-12): 35-45
Eichler, W.; Yafai, Y.; Kuhrt, H.; Gräter, R.; Hoffmann, S.; Wiedemann, P.; Reichenbach, A. 2001: Hypoxia: modulation of endothelial cell proliferation by soluble factors released by retinal cells. Neuroreport 12(18): 4103-4108
Brahimi-Horn, C.; Berra, E.; Pouysségur, J. 2001: Hypoxia: The tumor's gateway to progression along the angiogenic pathway. Trends in Cell Biology 11(11): S32-S36
Stenmark, K.R.; Gerasimovskaya, E.; Nemenoff, R.A.; Das, M. 2002: Hypoxic activation of adventitial fibroblasts: role in vascular remodeling. Chest 122(6 Suppl): 326s-334s
Jovanovic, S.; Land, S.C.; Olver, R.E.; Wilson, S.M. 2001: Hypoxic activation of an amiloride-sensitive cation conductance in alveolar epithelial cells. Biochemical and Biophysical Research Communications 286(3): 622-627
Chun, Y.-S.; Hyun, J.-Y.; Kwak, Y.-G.; Kim, I.-S.; Kim, C.-H.; Choi, E.; Kim, M.-S.; Park, J.-W. 2003: Hypoxic activation of the atrial natriuretic peptide gene promoter through direct and indirect actions of hypoxia-inducible factor-1. Biochemical Journal 370(Part 1): 149-157
Scano, G.; Filippelli, M.; Romagnoli, I.; Mancini, M.; Misuri, G.; Duranti, R.; Rosi, E. 2000: Hypoxic and hypercapnic breathlessness in patients with type I diabetes mellitus. Chest 117(4): 960-967
Spoto, G.; Di Giulio, C.; Contento, A.; Di Stilio, M. 1998: Hypoxic and hyperoxic effect on blood phosphodiesterase activity in young and old rats. Life Sciences 63(25): PL349-PL353
Horn, E.M.; Waldrop, T.G. 2000: Hypoxic augmentation of fast-inactivating and persistent sodium currents in rat caudal hypothalamic neurons. Journal of Neurophysiology 84(5): 2572-2581
Schepetkin, I.A. 1999: Hypoxic bioreducing agents: Possible immune and receptor-mediated mechanisms of an antineoplastic effect. Eksperimental'naya i Klinicheskaya Farmakologiya 62(3): 67-74
Schäbitz, W.R.; Berger, C.; Knauth, M.; Meinck, H.M.; Steiner, T. 2001: Hypoxic brain damage after intramuscular self-injection of diclofenac for acute back pain. European Journal of Anaesthesiology 18(11): 763-765
Hoffman, W.E.; Wheeler, P.; Edelman, G.; Charbel, F.T.; Torres, N.J.; Ausman, J.I. 2000: Hypoxic brain tissue following subarachnoid hemorrhage. Anesthesiology 92(2): 442-446
Schroedl, C.; McClintock, D.S.; Budinger, G.R.S.; Chandel, N.S. 2002: Hypoxic but not anoxic stabilization of HIF-1alpha requires mitochondrial reactive oxygen species. American Journal of Physiology. Lung Cellular and Molecular Physiology 283(5): L922-L931
Omata, N.; Murata, T.; Fujibayashi, Y.; Waki, A.; Sadato, N.; Yoshimoto, M.; Wada, Y.; Yonekura, Y. 2000: Hypoxic but not ischemic neurotoxicity of free radicals revealed by dynamic changes in glucose metabolism of fresh rat brain slices on positron autoradiography. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 20(2): 350-358
Höckel, M.; Schlenger, K.; Höckel, S.; Vaupel, P. 1999: Hypoxic cervical cancers with low apoptotic index are highly aggressive. Cancer Research 59(18): 4525-4528
Obara, D.; Utsugisawa, K.; Nagane, Y.; Tohgi, H. 2002: Hypoxic condition interferes with phosphorylation of Akt at Thr(308) in cultured rat pheochromocytoma-12 cells. Neuroscience Letters 332(3): 167-170
Kakihara, N.; Takeshita, K.; Ishibashi, H.; Tani, T.; Kodama, M. 2000: Hypoxic conditions restore lost sensitivity to the growth inhibitory effect of Transforming Growth Factor beta-1 (TGF beta-1) in proliferating rat hepatocytes in vitro. Life Sciences 67(24): 2929-2940
Liu, Q.; Sham, J.S.; Shimoda, L.A.; Sylvester, J.T. 2001: Hypoxic constriction of porcine distal pulmonary arteries: endothelium and endothelin dependence. American Journal of Physiology. Lung Cellular and Molecular Physiology 280(5): L856-L865
Dambska, M.; Gajkowska, B. 2002: Hypoxic damage of the cerebellum in 7-day-old rats. Ultrastructural and histochemical study. Acta Neurobiologiae Experimentalis 62(1): 45-49
Plant, L.D.; Kemp, P.J.; Peers, C.; Henderson, Z.; Pearson, H.A. 2002: Hypoxic depolarization of cerebellar granule neurons by specific inhibition of TASK-1. Stroke 33(9): 2324-2328
Fenelon, K.; Seifert, E.L.; Mortola, J.P. 2000: Hypoxic depression of circadian oscillations in sino-aortic denervated rats. Respiration Physiology 122(1): 61-69
Mortola, J.P.; Seifert, E.L. 2000: Hypoxic depression of circadian rhythms in adult rats. Journal of Applied Physiology 88(2): 365-368
Coiro; Poucher; Miller 2000: Hypoxic effects on growth of Palaemonetes vulgaris larvae and other species: Using constant exposure data to estimate cyclic exposure response. Journal of Experimental Marine Biology and Ecology 247(2): 243-255
Barashnev, Y., I. 2002: Hypoxic encephalopathy: Hypotheses of the pathogenesis of cerebral disorders and search for drug therapies. Rossiiskii Vestnik Perinatologii i Pediatrii 47(1): 6-13
Webster, N.J.; Vaughan, P.F.; Peers, C. 2001: Hypoxic enhancement of evoked noradrenaline release from the human neuroblastoma SH-SY5Y. Brain Research. Molecular Brain Research 89(1-2): 50-57
Taylor, S.C.; Batten, T.F.; Peers, C. 1999: Hypoxic enhancement of quantal catecholamine secretion. Evidence for the involvement of amyloid beta-peptides. Journal of Biological Chemistry 274(44): 31217-31222
Tajima, R.; Kawaguchi, N.; Horino, Y.; Takahashi, Y.; Toriyama, K.; Inou, K.; Torii, S.; Kitagawa, Y. 2001: Hypoxic enhancement of type IV collagen secretion accelerates adipose conversion of 3T3-L1 fibroblasts. Biochimica et Biophysica Acta 1540(3): 179-187
Schmid, H.-Peter; Harzhauser, M.; Kroh, A.; Coric, S.; Roegl, F.; Schultz, O. 2000: Hypoxic events on a Middle Miocene carbonate platform of the Central Paratethys (Austria, Badenian, 14 Ma). Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie 102A: 1-50
Mazza, E.; Edelman, N.H.; Neubauer, J.A. 2000: Hypoxic excitation in neurons cultured from the rostral ventrolateral medulla of the neonatal rat. Journal of Applied Physiology 88(6): 2319-2329
Henrion, J.; Minette, P.; Colin, L.; Schapira, M.; Delannoy, A.; Heller, F.R. 1999: Hypoxic hepatitis caused by acute exacerbation of chronic respiratory failure: a case-controlled, hemodynamic study of 17 consecutive cases. Hepatology 29(2): 427-433
Evans, S.M.; Hahn, S.M.; Magarelli, D.P.; Koch, C.J. 2001: Hypoxic heterogeneity in human tumors: EF5 binding, vasculature, necrosis, and proliferation. American Journal of Clinical Oncology 24(5): 467-472
Yang, X.; Sheares, K.K.K.; Davie, N.; Upton, P.D.; Taylor, G.W.; Horsley, J.; Wharton, J.; Morrell, N.W. 2002: Hypoxic induction of cox-2 regulates proliferation of human pulmonary artery smooth muscle cells. American Journal of Respiratory Cell and Molecular Biology 27(6): 688-696
Ogita, T.; Hashimoto, E.; Yamasaki, M.; Nakaoka, T.; Matsuoka, R.; Kira, Y.; Fujita, T. 2001: Hypoxic induction of adrenomedullin in cultured human umbilical vein endothelial cells. Journal of Hypertension 19(3 Pt 2): 603-608
Kim, N-Gon.; Lee, H.; Son, E.; Kwon, O-Young.; Park, J-Yong.; Park, J-Hoon.; Cho, G.Jae.; Choi, W.Sung.; Suk, K. 2003: Hypoxic induction of caspase-11/caspase-1/interleukin-1beta in brain microglia. Brain Research. Molecular Brain Research 114(2): 107-114
Enomoto, N.; Koshikawa, N.; Gassmann, M.; Hayashi, J.-I.; Takenaga, K. 2002: Hypoxic induction of hypoxia-inducible factor-1alpha and oxygen-regulated gene expression in mitochondrial DNA-depleted Hela cells. Biochemical and Biophysical Research Communications 297(2): 346-352
Jung, F.; Haendeler, J.; Hoffmann, Jörg.; Reissner, A.; Dernbach, E.; Zeiher, A.M.; Dimmeler, S. 2002: Hypoxic induction of the hypoxia-inducible factor is mediated via the adaptor protein Shc in endothelial cells. Circulation Research 91(1): 38-45
Sinor, A.D.; Irvin, S.M.; Cobbs, C.S.; Chen, J.; Graham, S.H.; Greenberg, D.A. 1998: Hypoxic induction of vascular endothelial growth factor (VEGF) protein in astroglial cultures. Brain Research 812(1-2): 289-291
Yelmen, N.K.; Sahin, G.ül.; Oruç, T.; Hacibekiroğlu, M.ün. 2003: Hypoxic initiation of pulmonary hypertension is mediated by serotonin secretion from neuroepithelial bodies in chemodenervated dogs. Chinese Journal of Physiology 46(1): 27-33
Sato, Y.; Okumura, A.; Kato, T.; Hayakawa, F.; Kuno, K.; Watanabe, K. 2003: Hypoxic ischemic encephalopathy associated with neonatal seizures without other neurological abnormalities. Brain and Development 25(3): 215-219
Itoo, B.A.; Al-Hawsawi, Z.M.; Khan, A.H. 2003: Hypoxic ischemic encephalopathy. Incidence and risk factors in North Western Saudi Arabia. Saudi Medical Journal 24(2): 147-153
Davenport, J.; Irwin, S. 2003: Hypoxic life of intertidal acorn barnacles. ine Biology Berlin 143(3): 555-563
Chen, E.Y.; Fujinaga, M.; Giaccia, A.J. 1999: Hypoxic microenvironment within an embryo induces apoptosis and is essential for proper morphological development. Teratology 60(4): 215-225
Baek, S.H.; Han, M.Y.; Lee, S.H.; Choi, E.M.; Park, Y.M. 1999: Hypoxic microenvironmental control of stress protein and erythropoietin gene expression. Journal of Biochemistry and Molecular Biology 32(2): 112-118
Mironov, S.L.; Richter, D.W. 2000: Hypoxic modulation of L-type Ca(2+) channels in inspiratory brainstem neurones: intracellular signalling pathways and metabotropic glutamate receptors. Brain Research 869(1-2): 166-177
Ohman, T.; Parish, G.; Jackson, R.M. 1999: Hypoxic modulation of manganese superoxide dismutase promoter activity and gene expression in lung epithelial cells. American Journal of Respiratory Cell and Molecular Biology 21(1): 119-127
Park, L.; Thornhill, J. 2000: Hypoxic modulation of striatal lesions induced by administration of endothelin-1. Brain Research 883(1): 51-59
Guadagni, S.; Santinami, M.; Patuzzo, R.; Pilati, P.L.; Miotto, D.; Deraco, M.; Rossi, C.R.; Fiorentini, G.; Di Filippo, F.; Valenti, M.; Amicucci, G. 2003: Hypoxic pelvic and limb perfusion with melphalan and mitomycin C for recurrent limb melanoma: a pilot study. Melanoma Research 13(1): 51-58
Akita, T.; Murohara, T.; Ikeda, H.; Sasaki, K-Ichiro.; Shimada, T.; Egami, K.; Imaizumi, T. 2003: Hypoxic preconditioning augments efficacy of human endothelial progenitor cells for therapeutic neovascularization. Laboratory Investigation; a Journal of Technical Methods and Pathology 83(1): 65-73
Zhao, T.; Yu, S.; Ding, A.S.; Wang, F.Z.; Fan, M. 2001: Hypoxic preconditioning enhances hypoxic tolerance of hippocampal neurons and synaptic function of rat. Sheng Li Xue Bao: 53(1): 72-74
Jones, N.M.; Bergeron, M. 2001: Hypoxic preconditioning induces changes in HIF-1 target genes in neonatal rat brain. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 21(9): 1105-1114
Liu, J.; Ginis, I.; Spatz, M.; Hallenbeck, J.M. 2000: Hypoxic preconditioning protects cultured neurons against hypoxic stress via TNF-alpha and ceramide. American Journal of Physiology. Cell Physiology 278(1): C144-C153
Cantagrel, S.; Krier, C.; Ducrocq, S.; Bodard, S.; Payen, Vérie.; Laugier, J.; Guilloteau, D.; Chalon, S. 2003: Hypoxic preconditioning reduces apoptosis in a rat model of immature brain hypoxia-ischaemia. Neuroscience Letters 347(2): 106-110
Sasaki, H.; Fukuda, S.; Otani, H.; Zhu, L.; Yamaura, G.; Engelman, R.M.; Das, D.K.; Maulik, N. 2002: Hypoxic preconditioning triggers myocardial angiogenesis: a novel approach to enhance contractile functional reserve in rat with myocardial infarction. Journal of Molecular and Cellular Cardiology 34(3): 335-348
Kraiczi, H.; Magga, J.; Sun, X.Y.; Ruskoaho, H.; Zhao, X.; Hedner, J. 1999: Hypoxic pressor response, cardiac size, and natriuretic peptides are modified by long-term intermittent hypoxia. Journal of Applied Physiology 87(6): 2025-2031
Movsas, B.; Chapman, J.Donald.; Hanlon, A.L.; Horwitz, E.M.; Greenberg, R.E.; Stobbe, C.; Hanks, G.E.; Pollack, A. 2002: Hypoxic prostate/muscle Po2 ratio predicts for biochemical failure in patients with prostate cancer: Preliminary findings. Urology 60(4): 634-639
Rose, F.; Grimminger, F.; Appel, J.; Heller, M.; Pies, V.; Weissmann, N.; Fink, L.; Schmidt, S.; Krick, S.; Camenisch, G.; Gassmann, M.; Seeger, W.; Hänze, Jörg. 2002: Hypoxic pulmonary artery fibroblasts trigger proliferation of vascular smooth muscle cells: role of hypoxia-inducible transcription factors. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 16(12): 1660-1661
Ullrich, R.; Bloch, K.D.; Ichinose, F.; Steudel, W.; Zapol, W.M. 1999: Hypoxic pulmonary blood flow redistribution and arterial oxygenation in endotoxin-challenged NOS2-deficient mice. Journal of Clinical Investigation 104(10): 1421-1429
Weitzenblum, E.; Chaouat, A. 2001: Hypoxic pulmonary hypertension in man: what minimum daily duration of hypoxaemia is required?. European Respiratory Journal 18(2): 251-253
Dumas, J.P.; Bardou, M.; Goirand, F.; Dumas, M. 1999: Hypoxic pulmonary vasoconstriction. General Pharmacology 33(4): 289-297
Castañeda, J.; Isusi, A.; Tamayo, L. 2001: Hypoxic pulmonary vasoconstriction increases during endotoxemia in the perfused rat lung. Journal of Trauma 50(5): 882-886
Zhu, D.; Birks, E.K.; Dawson, C.A.; Patel, M.; Falck, J.R.; Presberg, K.; Roman, R.J.; Jacobs, E.R. 2000: Hypoxic pulmonary vasoconstriction is modified by P-450 metabolites. American Journal of Physiology. Heart and Circulatory Physiology 279(4): H1526-H1533
Sylvester, J.T. 2001: Hypoxic pulmonary vasoconstriction: a radical view. Circulation Research 88(12): 1228-1230
Evans, A.Mark.; Dipp, M. 2002: Hypoxic pulmonary vasoconstriction: cyclic adenosine diphosphate-ribose, smooth muscle Ca(2+) stores and the endothelium. Respiratory Physiology and Neurobiology 132(1): 3-15
Sham, J.S.K. 2002: Hypoxic pulmonary vasoconstriction: ups and downs of reactive oxygen species. Circulation Research 91(8): 649-651
Hoskin, P.J.; Saunders, M.I.; Dische, S. 1999: Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma: Hyperbaric oxygen, misonidazole, and accelerated radiotherapy, carbogen, and nicotinamide. Cancer 86(7): 1322-1328
Movsas, B.; Chapman, J.D.; Horwitz, E.M.; Pinover, W.H.; Greenberg, R.E.; Hanlon, A.L.; Iyer, R.; Hanks, G.E. 1999: Hypoxic regions exist in human prostate carcinoma. Urology 53(1): 11-18
Jung, F.; Palmer, L.A.; Zhou, N.; Johns, R.A. 2000: Hypoxic regulation of inducible nitric oxide synthase via hypoxia inducible factor-1 in cardiac myocytes. Circulation Research 86(3): 319-325
Dibbens, J.A.; Miller, D.L.; Damert, A.; Risau, W.; Vadas, M.A.; Goodall, G.J. 1999: Hypoxic regulation of vascular endothelial growth factor mRNA stability requires the cooperation of multiple RNA elements. Molecular Biology of the Cell 10(4): 907-919
Smith, I.F.; Boyle, J.P.; Plant, L.D.; Pearson, H.A.; Peers, C. 2003: Hypoxic remodeling of Ca2+ stores in type i cortical astrocytes. Journal of Biological Chemistry 278(7): 4875-4881
Buono, R.J.; Lang, R.K. 1999: Hypoxic repression of lactate dehydrogenase-B in retina. Experimental Eye Research 69(6): 685-693
Corne, S.; Webster, K.; Younes, M. 2003: Hypoxic respiratory response during acute stable hypocapnia. American Journal of Respiratory and Critical Care Medicine 167(9): 1193-1199
Rosenkrands, I.; Slayden, R.A.; Crawford, J.; Aagaard, C.; Barry, C.E.; Andersen, P. 2002: Hypoxic response of Mycobacterium tuberculosis studied by metabolic labeling and proteome analysis of cellular and extracellular proteins. Journal of Bacteriology 184(13): 3485-3491
Buonocore, G.; Liberatori, S.; Bini, L.; Mishra, O.P.; Delivoria-Papadopoulos, M.; Pallini, V.; Bracci, R. 1999: Hypoxic response of synaptosomal proteins in term guinea pig fetuses. Journal of Neurochemistry 73(5): 2139-2148
Stepanov, O.G. 2002: Hypoxic stimulation as a method for increasing the detoxification function of the liver. Izvestiya Vysshikh Uchebnykh Zavedenii Severo-Kavkazskii Region Estestvennye Nauki 1: 112-113
Ankoma-Sey, V.; Wang, Y.; Dai, Z. 2000: Hypoxic stimulation of vascular endothelial growth factor expression in activated rat hepatic stellate cells. Hepatology 31(1): 141-148
Hishinuma, S.; Funamoto, M.; Fujio, Y.; Kunisada, K.; Yamauchi-Takihara, K. 1999: Hypoxic stress induces cardiotrophin-1 expression in cardiac myocytes. Biochemical and Biophysical Research Communications 264(2): 436-440
Maruoka, N.; Murata, T.; Omata, N.; Fujibayashi, Y.; Yonekura, Y.; Wada, Y. 2002: Hypoxic tolerance induction in rat brain slices following 3-nitropropionic acid pretreatment as revealed by dynamic changes in glucose metabolism. Neuroscience Letters 319(2): 83-86
Omata, N.; Murata, T.; Takamatsu, S.; Maruoka, N.; Wada, Y.; Yonekura, Y.; Fujibayashi, Y. 2002: Hypoxic tolerance induction in rat brain slices following hypoxic preconditioning due to expression of neuroprotective proteins as revealed by dynamic changes in glucose metabolism. Neuroscience Letters 329(2): 205-208
Hehlgans, T.; Seitz, C.; Lewis, C.; Männel, D.N. 2001: Hypoxic upregulation of TNF receptor type 2 expression involves NF-IL-6 and is independent of HIF-1 or HIF-2. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 21(9): 757-762
Höhler, B.; Lange, B.; Holzapfel, B.; Goldenberg, A.; Hänze, J.; Sell, A.; Testan, H.; Möller, W.; Kummer, W. 1999: Hypoxic upregulation of tyrosine hydroxylase gene expression is paralleled, but not induced, by increased generation of reactive oxygen species in PC12 cells. FEBS Letters 457(1): 53-56
Weissmann, N.; Tadic, A.; Hänze, J.; Rose, F.; Winterhalder, S.; Nollen, M.; Schermuly, R.T.; Ghofrani, H.A.; Seeger, W.; Grimminger, F. 2000: Hypoxic vasoconstriction in intact lungs: a role for NADPH oxidase-derived H(2)O(2)?. American Journal of Physiology. Lung Cellular and Molecular Physiology 279(4): L683-L690
Bardou, M.; Goirand, F.; Marchand, S.; Rouget, C.; Devillier, P.; Dumas, J.P.; Morcillo, E.J.; Rochette, L.; Dumas, M. 2001: Hypoxic vasoconstriction of rat main pulmonary artery: role of endogenous nitric oxide, potassium channels, and phosphodiesterase inhibition. Journal of Cardiovascular Pharmacology 38(2): 325-334
Ralevic, V. 2002: Hypoxic vasodilatation: is an adenosine-prostaglandins- NO signalling cascade involved?. Journal of Physiology 544(Pt 1): 2
Thorne, G.D.; Conforti, L.; Paul, R.J. 2002: Hypoxic vasorelaxation inhibition by organ culture correlates with loss of Kv channels but not Ca(2+) channels. American Journal of Physiology. Heart and Circulatory Physiology 283(1): H247-H253
Murakami, T.; Hattori, N.; Fujimori, T.; Saijo, Y. 2002: Hypoxic water development and disappearance at up- and downstream near the rivermouth barrage in the Nagara River, Central Japan. Japanese Journal of Limnology 63(1): 72-73
Rosenberger, A.E.; Chapman, L.J. 1999: Hypoxic wetland tributaries as faunal refugia from an introduced predator. Ecology of Freshwater Fish 8(1): 22-34
Zornberg, G.L.; Buka, S.L.; Tsuang, M.T. 2000: Hypoxic-ischemia-related fetal/neonatal complications and risk of schizophrenia and other nonaffective psychoses: a 19-year longitudinal study. American Journal of Psychiatry 157(2): 196-202
Peters, B.; Walka, M.M.; Friedmann, W.; Stoltenburg-Didinger, G.; Obladen, M. 2000: Hypoxic-ischemic encephalopathy with cystic brain stem necroses and thalamic calcifications in a preterm twin. Brain and Development 22(4): 265-271
Cowell, R.M.; Xu, H.; Galasso, J.M.; Silverstein, F.S. 2002: Hypoxic-ischemic injury induces macrophage inflammatory protein-1alpha expression in immature rat brain. Stroke 33(3): 795-801
Skoff, R.P.; Bessert, D.A.; Barks, J.D.; Song, D.; Cerghet, M.; Silverstein, F.S. 2001: Hypoxic-ischemic injury results in acute disruption of myelin gene expression and death of oligodendroglial precursors in neonatal mice. International Journal of Developmental Neuroscience: the Official Journal of the International Society for Developmental Neuroscience 19(2): 197-208
Liu, Y.; Silverstein, F.S.; Skoff, R.; Barks, J.D.E. 2002: Hypoxic-ischemic oligodendroglial injury in neonatal rat brain. Pediatric Research 51(1): 25-33
Andersen, S.N.; Skullerud, K. 1999: Hypoxic/ischaemic brain damage, especially pallidal lesions, in heroin addicts. Forensic Science International 102(1): 51-59
Cheepsunthorn, P.; Palmer, C.; Menzies, S.; Roberts, R.L.; Connor, J.R. 2001: Hypoxic/ischemic insult alters ferritin expression and myelination in neonatal rat brains. Journal of Comparative Neurology 431(4): 382-396
V.K.enigswald, W.; Goin, F.; Pascual, R. 1999: Hypsodonty and enamel microstructure in the Paleocene gondwanatherian mammal Sudamerica ameghinoi. Acta Palaeontologica Polonica 44(3): 263-300
Candela, A.-Magdalena; Vucetich, M.-Guiomar 2002: Hypsosteiromys (Rodentia, Hystricognathi) from the Early Miocene of Patagonia (Argentina), the only Erethizontidae with a tendency to hypsodonty. Geobios 35(1): 153-160
Fritzen, N.R. 2002: Hyptiotes paradoxus (Araneae: Uloboridae) found on the Aland Islands: A species new to Finland. Memoranda Societatis pro Fauna et Flora Fennica 78(1): 3-7
Harley, R.M. 2003: Hyptis bahiensis Harley: A new species of Labiatae from Brazil. Kew Bulletin 58(2): 479-483
Xu, A.; Chen, K.Y. 2001: Hypusine is required for a sequence-specific interaction of eukaryotic initiation factor 5A with postsystematic evolution of ligands by exponential enrichment RNA. Journal of Biological Chemistry 276(4): 2555-2561
Rhodes, J.C.; Kjerulff, K.H.; Langenberg, P.W.; Guzinski, G.M. 1999: Hysterectomy and sexual functioning. JAMA 282(20): 1934-1941
Roovers, J.-P.W.R.; van der Bom, J.G.; van der Vaart, C.H.; Heintz, A.P.M. 2003: Hysterectomy and sexual wellbeing: prospective observational study of vaginal hysterectomy, subtotal abdominal hysterectomy, and total abdominal hysterectomy. Bmj 327(7418): 774-778
Materia, E.; Rossi, L.; Spadea, T.; Cacciani, L.; Baglio, G.; Cesaroni, G.; Arcà, M.; Perucci, C.A. 2002: Hysterectomy and socioeconomic position in Rome, Italy. Journal of Epidemiology and Community Health 56(6): 461-465
Brown, J.S.; Sawaya, G.; Thom, D.H.; Grady, D. 2000: Hysterectomy and urinary incontinence: a systematic review. Lancet 356(9229): 535-539
Martin, X.; Gjata, A.; Golfier, F.; Raudrant, D. 1999: Hysterectomy for a benign lesion: can the vaginal route be used in all cases?. Journal de Gynecologie Obstetrique et Biologie de la Reproduction 28(2): 124-130
Eltabbakh, G.H.; Shamonki, M.I.; Moody, J.M.; Garafano, L.L. 2000: Hysterectomy for obese women with endometrial cancer: laparoscopy or laparotomy?. Gynecologic Oncology 78(3 Part 1): 329-335
Unger, J.B.; Paul, R.; Caldito, G. 2002: Hysterectomy for the massive leiomyomatous uterus. Obstetrics and Gynecology 100(6): 1271-1275
Weaver, F.; Hynes, D.; Goldberg, J.M.; Khuri, S.; Daley, J.; Henderson, W. 2001: Hysterectomy in Veterans Affairs Medical Centers. Obstetrics and Gynecology 97(6): 880-884
Newman, C.; Finan, M.A. 2003: Hysterectomy in women with cervical stenosis. Surgical indications and pathology. Journal of Reproductive Medicine 48(9): 672-676
Kirchengast, S.; Gruber, D.; Sator, M.; Huber, J. 2000: Hysterectomy is associated with postmenopausal body composition characteristics. Journal of Biosocial Science 32(1): 37-46
Kovac, S.R. 2000: Hysterectomy outcomes in patients with similar indications. Obstetrics and Gynecology 95(6 Pt 1): 787-793
Brett, K.M.; Higgins, J.A. 2003: Hysterectomy prevalence by Hispanic ethnicity: evidence from a national survey. American Journal of Public Health 93(2): 307-312
Farquhar, C.M.; Steiner, C.A. 2002: Hysterectomy rates in the United States 1990-1997. Obstetrics and Gynecology 99(2): 229-234
Chapron, C.; Laforest, L.; Ansquer, Y.; Fauconnier, A.; Fernandez, B.; Bréart, G.; Dubuisson, J.B. 1999: Hysterectomy techniques used for benign pathologies: results of a French multicentre study. Human Reproduction 14(10): 2464-2470
Kritz-Silverstein, D.; Barrett-Connor, E. 2002: Hysterectomy, oophorectomy, and cognitive function in older women. Journal of the American Geriatrics Society 50(1): 55-61
Laughlin, G.A.; Barrett-Connor, E.; Kritz-Silverstein, D.; von Mühlen, D. 2000: Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. Journal of Clinical Endocrinology and Metabolism 85(2): 645-651
Sha, W.; Moore, J.; Chen, K.; Lassaletta, A.D.; Yi, C.-S.; Tyson, J.J.; Sible, J.C. 2003: Hysteresis drives cell-cycle transitions in Xenopus laevis egg extracts. Proceedings of the National Academy of Sciences of the United States of America 100(3): 975-980
Kara, S.; Tamerler, C.; Bermek, H.; Pekcan, O. 2003: Hysteresis during sol-gel and gel-sol phase transitions of kappa-carrageenan: A photon transmission study. Journal of Bioactive and Compatible Polymers 18(1): 33-44
Kimura, T.; Yamanaka, K.; Nozaki, D.; Nakazawa, K.; Miyoshi, T.; Akai, M.; Ohtsuki, T. 2003: Hysteresis in corticospinal excitability during gradual muscle contraction and relaxation in humans. Experimental Brain Research 152(1): 123-132
Shapiro, B.E.; Qian, H. 1998: Hysteresis in force probe measurements: a dynamical systems perspective. Journal of Theoretical Biology 194(4): 551-559
Maganaris, C.N.; Paul, J.P. 2000: Hysteresis measurements in intact human tendon. Journal of Biomechanics 33(12): 1723-1727
Del Pino, M.M.; Corrales, F.J.; Mato, J.M. 2000: Hysteretic behavior of methionine adenosyltransferase III. Methionine switches between two conformations of the enzyme with different specific activity. Journal of Biological Chemistry 275(31): 23476-23482
Behzadi, A.; Hatleskog, R.; Ruoff, P. 1999: Hysteretic enzyme adaptation to environmental pH: change in storage pH of alkaline phosphatase leads to a pH-optimum in the opposite direction to the applied change. Biophysical Chemistry 77(2-3): 99-109
Fisher, C.M. 1999: Hysteria: a delusional state. Medical Hypotheses 53(2): 152-156
Vasilyeva, L.N. 2001: Hysteriaceous fungi in the Russian Far East IV. Glyphium, Lophium and Mytilinidion. Mikologiya i Fitopatologiya 35(1): 15-18
Vasilyeva, L.N. 1999: Hysteriaceous fungi in the Russian Far East: I. Hysterium. Mikologiya i Fitopatologiya 33(4): 225-227
Vasilyeva, L.N. 1999: Hysteriaceous fungi in the Russian Far East: II. The genus Hysterographium. Mikologiya i Fitopatologiya 33(5): 297-300
Skinner, J.; Leavy, J.; Stuart, B.J.; Turner, M.J. 2000: Hysterosalpingocontrastsonography in clinical practice. Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology 20(2): 171-174
Piyavisetpat, N.; Mahayosnond, A.; Wangsuphachart, S. 2002: Hysterosalpingographic accuracy of peritubal adhesion. Journal of the Medical Association of Thailand 85(Suppl): S210-S216
Kriplani, A.; Agarwal, N. 2001: Hysteroscopic and laparoscopic guided miniaccess hemihysterectomy for non-communicating uterine horn. Archives of Gynecology and Obstetrics 265(3): 162-164
Leung, P.Ling.; Tam, W.Hung.; Yuen, P.Mo. 2003: Hysteroscopic appearance of the endometrial cavity following thermal balloon endometrial ablation. Fertility and Sterility 79(5): 1226-1228
Masamoto, H.; Nakama, K.; Kanazawa, K. 2000: Hysteroscopic appearance of the mid-secretory endometrium: relationship to early phase pregnancy outcome after implantation. Human Reproduction 15(10): 2112-2118
Lorenzo, F.; Gonzalez, M.; Romano, F.; Scarano, D.; Bagnati, A.; Goldman, A.; Mizyricky, S. 2000: Hysteroscopic appearances in patients with breast cancer receiving tamoxifen with ultrasonographic diagnosis of endometrial enlargement. Prensa Medica Argentina 87(3): 239-240
Garuti, G.; Grossi, F.; Cellani, F.; Centinaio, G.; Colonnelli, M.; Luerti, M. 2002: Hysteroscopic assessment of menopausal breast-cancer patients taking tamoxifen; there is a bias from the mode of endometrial sampling in estimating endometrial morbidity?. Breast Cancer Research and Treatment 72(3): 245-253
Noyes, N. 1999: Hysteroscopic cervical canal shaving: A new therapy for cervical stenosis before embryo transfer in patients undergoing in vitro fertilization. Fertility and Sterility 71(5): 965-966
Bacskó, G.; Major, T. 1999: Hysteroscopic diagnosis and treatment of endometrial polyps. Orvosi Hetilap 140(37): 2041-2045
Rose, P.G.; Mendelsohn, G.; Kornbluth, I. 1998: Hysteroscopic dissemination of endometrial carcinoma. Gynecologic Oncology 71(1): 145-146
Lo, K.W.K.; Cheung, T.H.; Yim, S.F.; Chung, T.K.H. 2002: Hysteroscopic dissemination of endometrial carcinoma using carbon dioxide and normal saline: a retrospective study. Gynecologic Oncology 84(3): 394-398
Laframboise, S.; Milosevic, M.; Leyland, N. 1999: Hysteroscopic endometrial resection and high-dose-rate brachytherapy: treatment of endometrial cancer in a medically compromised patient. Gynecologic Oncology 75(1): 149-151
Zupi, E.; Zullo, F.; Marconi, D.; Sbracia, M.; Pellicano, M.; Solima, E.; Sorrenti, G. 2003: Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: A prospective randomized trial. American Journal of Obstetrics and Gynecology 188(1): 7-12
Gonçalves, M.A.; Gonçalves, W.J.; Matias, M.M.; Nazario, A.C.; de Lima, G.R.; Baracat, E.C. 1999: Hysteroscopic evaluation of the endometrium of post-menopausal patients with breast cancer before and after tamoxifen use. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 66(3): 273-279
Perrone, G.; Deangelis, C.; Critelli, C.; Capri, O.; Galoppi, P.; Santoro, G.; Nofroni, I.; Zichella, L. 2002: Hysteroscopic findings in postmenopausal abnormal uterine bleeding: A comparison between HRT users and non-users. Maturitas 43(4): 251-255
Sanz, L.E.; Verosko, J. 2002: Hysteroscopic management of cornual ectopic pregnancy. Obstetrics and Gynecology 99(5 Pt 2): 941-944
Porcu, G.; Cravello, L.; D'Ercole, C.; Cohen, D.; Roger, V.; de Montgolfier, R.; Blanc, B. 2000: Hysteroscopic metroplasty for septate uterus and repetitive abortions: Reproductive outcome. European Journal of Obstetrics Gynecology and Reproductive Biology 88(1): 81-84
Rock, J.A.; Roberts, C.P.; Hesla, J.S. 1999: Hysteroscopic metroplasty of the Class Va uterus with preservation of the cervical septum. Fertility and Sterility 72(5): 942-945
Vercellini, P.; Zàina, B.; Yaylayan, L.; Pisacreta, A.; De Giorgi, O.; Crosignani, P.G. 1999: Hysteroscopic myomectomy: Long-term effects on menstrual pattern and fertility. Obstetrics and Gynecology 94(3): 341-347
Darwish, A.M.; Makhlouf, A.M.; Youssof, A.A.; Gadalla, H.A. 1999: Hysteroscopic myometrial biopsy in unexplained abnormal uterine bleeding. European Journal of Obstetrics Gynecology and Reproductive Biology 86(2): 139-143
Xia, E.; Duan, H.; Huang, X.; Zheng, J.; Yu, D.; Cheng, L. 2003: Hysteroscopic removal of foreign bodies and its method of monitoring. Chinese Medical Journal 116(1): 125-128
Fernandez, H.; Sefrioui, O.; Virelizier, C.; Gervaise, A.; Gomel, V.; Frydman, R. 2001: Hysteroscopic resection of submucosal myomas in patients with infertility. Human Reproduction 16(7): 1489-1492
Inagaki, N.; Sato, K.; Toyoshima, K.; Ito, K.; Kitai, H.; Gabionza, D.T.; Yoshimura, Y. 1999: Hysteroscopic selective salpingography. Fertility and Sterility 72(4): 733-736
Kerin, J.F.; Cooper, J.M.; Price, T.; Herendael, B.J.Van.; Cayuela-Font, E.; Cher, D.; Carignan, C.S. 2003: Hysteroscopic sterilization using a micro-insert device: Results of a multicentre phase II study. Human Reproduction 18(6): 1223-1230
Pellicano, M.; Guida, M.; Acunzo, G.; Cirillo, D.; Bifulco, G.; Nappi, C. 2002: Hysteroscopic transcervical endometrial resection versus thermal destruction for menorrhagia: A prospective randomized trial on satisfaction rate. American Journal of Obstetrics and Gynecology 187(3): 545-550
Capella-Allouc, S.; Morsad, F.; Rongières-Bertrand, C.; Taylor, S.; Fernandez, H. 1999: Hysteroscopic treatment of severe Asherman's syndrome and subsequent fertility. Human Reproduction 14(5): 1230-1233
Hickok, L.R. 2000: Hysteroscopic treatment of the uterine septum: a clinician's experience. American Journal of Obstetrics and Gynecology 182(6): 1414-1420
Garuti, G.; Sambruni, I.; Cellani, F.; Garzia, D.; Alleva, P.; Luerti, M. 1999: Hysteroscopy and transvaginal ultrasonography in postmenopausal women with uterine bleeding. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 65(1): 25-33
Spiewankiewicz, B.; Stelmachów, J.; Sawicki, W.; Cendrowski, K.; Kuźlik, R. 2003: Hysteroscopy in cases of cervical polyps. European Journal of Gynaecological Oncology 24(1): 67-69
Williams, A.S.; Kost, E.R.; Hermann, J.; Zahn, C. 2002: Hysteroscopy in the evaluation and treatment of mucinous adenocarcinoma. Obstetrics and Gynecology 99(3): 509-511
Deckers, E.A.; Stamm, C.A.; Naake, V.L.; Dunn, T.S.; McFee, J.G. 2000: Hysterotomy for retained placenta in a term angular pregnancy. A case report. Journal of Reproductive Medicine 45(2): 153-155
Jorge, L.-Ilza-Ferreira; Graciano, R.-Alexandre-Silva; Prado, S.-De-Paula-Toledo; Pereira, U. 1999: Hystological identification of Sambucus australis Cham. and Schlecht. (elder). Revista de Ciencias Farmaceuticas 20(1): 117-123
Ratti, E.; Busato, L. 2000: I Carabidi d'alcuni biotopi umidi artificiali della bassa pianura veneta (Coleoptera Carabidae). Bollettino del Museo Civico di Storia Naturale di Venezia 51: 119-128
Taglianti, A.-Vigna; Bonavita, P.; Di-Giulio, A.; Todini, A.; Maltzeff, P. 2001: I Carabidi della Tenuta Presidenziale di Castelporziano (Coleoptera, Carabidae). Bollettino dell'Associazione Romana di Entomologia 56(1-4): 115-173
Gomy, Y.; Vienna, P. 1999: I Chalcionellus Reichardt, 1932 della fauna afro-tropicale (Coleoptera, Histeridae). Nouvelle Revue d'Entomologie 16(4): 343-355
Monzini, V.; Romano, V.-Antonio 2001: I Coleotteri Carabidi del fiume Basento (Potenza): Nuovi dati per l'Italia meridionale e per la regione Basilicata (Coleoptera Carabidae). Bollettino della Societa Entomologica Italiana 133(1): 27-35
Carpaneto, G., M.; Ciceroni, A.; Piattella, E. 1999: I Coleotteri Scarabeoidei dei Monti Sabini (Lazio) (Coleoptera, Scarabaeoidea). Bollettino dell'Associazione Romana di Entomologia 54(1-4): 85-130
Bordoni, A.; Rocchi, S. 2000: I Coleotteri del Padule di Fucecchio nuovi dati faunistici e aggiornamenti tassonomici e nomenclatoriali (Coleoptera). Redia 83: 25-47
Volpi, C.; Callea, A.; Martignoni, R.; Borri, M. 2000: I Columbellidi delle coste somale (Gastropoda: Columbellidae). Bollettino Malacologico 36(9-12): 183-190
Casalini, R.; Colonnelli, E. 2001: I Curculionoidei della Tenuta Presidenziale di Castelporziano (Coleoptera, Curculionoidea). Bollettino dell'Associazione Romana di Entomologia 56(1-4): 331-352
Ruggerini, C.; Guaraldi, G.-Paolo; Neviani, V.; Solmi, A. 2002: I Disturbi mentali nel Ritardo Mentale Grave: Primi risultati della utilizzazione della scala DASH-II in una popolazione residenziale. Quaderni Italiani di Psichiatria 21(1): 46-52
Borgo, E. 1999: I Laridae del Museo Civico di Storia Naturale G. Doria di Genova. II. Larini (Aves). Annali del Museo Civico di Storia Naturale Giacomo Doria 93: 429-450
Scotti, G.; Chemello, R. 2000: I Molluschi marini mediterranei degni di protezione: stato delle conoscenze e forme di tutela. Bollettino Malacologico 36(1-4): 61-70
Dell'angelo, B.; Forli, M.; Lombardi, C. 2000: I Polyplacophora plio-pleistocenici della Toscana. Bollettino Malacologico 36(9-12): 143-154
Alicata, P.; Cantarella, T. 1999: I Salticidi di Sicilia: Stato della conoscenza e descrizione di due nuove specie (Araneae Salticidae). Memorie della Societa Entomologica Italiana 78(2): 485-498
Cerretti, P. 2001: I Tachinidi della Tenuta Presidenziale di Castelporziano (Diptera, Tachinidae). Bollettino dell'Associazione Romana di Entomologia 56(1-4): 63-113
Fattorini, S.; Maltzeff, P. 2001: I Tenebrionidi della Tenuta Presidenziale di Castelporziano (Coleoptera, Tenebrionidae). Bollettino dell'Associazione Romana di Entomologia 56(1-4): 245-300
Goldenberg, J.L.; Pyszczynski, T.; Greenberg, J.; Solomon, S.; Kluck, B.; Cornwell, R. 2001: I am not an animal: mortality salience, disgust, and the denial of human creatureliness. Journal of Experimental Psychology. General 130(3): 427-435
Palleschi, G.; Compagnone, D.; Moscone, D.; Volpe, G.; Esti, M.; Marconi, E. 2001: I biosensori: Utilizzazione per il controllo della qualita degli alimenti. Rivista di Scienza dell'Alimentazione 30(3 Suppl): 67-73
Giada, F.; Conte, R.; De-Piccoli, B.; Raviele, A. 2002: I disturbi del ritmo nell'atleta. Aspetti diagnostici e prognostici. Medicina dello Sport 55(2): 95-99
Burkovski, A. 2003: I do it my way: Regulation of ammonium uptake and ammonium assimilation in Corynebacterium glutamicum. Archives of Microbiology 179(2): 83-88
Dazzi, E.; Padalino, G.; Peretti, A. 2000: I fabbisogni di energia secondo i LARN: Possibilita di applicazione informatizzata alle ricerche territoriali. Rivista di Scienza dell'Alimentazione 29(1): 15-20
Fiore, D. 2000: I fattori immunologici nella patogenesi delle encefalo-medullopatie da B. Pertussis. EOS-Rivista di Immunologia ed Immunofarmacologia 20(3): 63-70
Naito, E.; Roland, P.E.; Ehrsson, H.Henrik. 2002: I feel my hand moving: A new role of the primary motor cortex in somatic perception of limb movement. Neuron 36(5): 979-988
Aschermann, M.; Widimský, P. 2002: I have an acute myocardial infarction: open my coronary artery, stent it and keep full flow!. European Heart Journal 23(12): 913-916
Umiltà, M.A.; Kohler, E.; Gallese, V.; Fogassi, L.; Fadiga, L.; Keysers, C.; Rizzolatti, G. 2001: I know what you are doing. a neurophysiological study. Neuron 31(1): 155-165
Trevisan, R.; Rosso, A. 1999: I laghi di Colbricon (Trentino Orientale): Principali caratteristiche morfometriche e limnologiche. Studi Trentini di Scienze Naturali Acta Biologica 76: 87-104
Grillo, M.; Carnemolla, G.; Carfi, M.-Grazia 2000: I licheni della valle dell'Ippari presso Vittoria e della zona archeologica di Camarina (Sicilia Orientale). Archivio Geobotanico 6(1): 45-58
Loppi, S.; Putorti, E. 2001: I licheni epifiti dell'Orto Botanico delle Alpi Apuane. Informatore Botanico Italiano 33(1): 15-16
Puntillo, D. 2000: I licheni foliicoli e i loro funghi lichenicoli in Italia. Allionia (Turin) (37): 241-248
Stoch, F. 1999: I macroinvertebrati delle acque interne del Friuli-Venezia Giulia (Italia nord-orientale): Anfipodi (Crustacea, Amphipoda). Gortania Atti del Museo Friulano di Storia Naturale 21: 133-160
Rocchi, S. 1999: I macroinvertebrati delle acque interne del Friuli-Venezia Giulia (Italia nord-orientale): Coleoptera hydroadephaga: Haliplidae, Gyrinidae, Dytiscidae. Gortania Atti del Museo Friulano di Storia Naturale 21: 203-222
Dell'angelo, B.; Plazzi, S.; Pavia, G. 1998: I molluschi del messiniano inferiore di Borelli (Torino). 4. polyplacophora. Museo Regionale di Scienze Naturali Bollettino 16(1-2): 257-302
Cobianchi, M. 2002: I nannofossili calcarei del Giurassico medio e superiore del Bacino di Belluno (Alpi Calcaree Meridionali). Atti Ticinensi di Scienze della Terra 43: 3-24
Antommaria, A.H. 2003: I paid out-of-pocket for my son's circumcision at Happy Valley Tattoo and Piercing: alternative framings of the debate over routine neonatal male circumcision. American Journal of Bioethics: Ajob 3(2): 50-52
Ducci, F.; Guidi, G. 1998: I pini della sez. halepensis, selezione e possibilita di impiego di specie e provenienze per l'Italia. Annali dell'Istituto Sperimentale per la Selvicoltura 29: 67-85
Ghidini, S.; Delbono, G.; Madarena, G.; Dazzi, G.; Chizzolini, R. 2000: I policlorobifenili (pcb): Una rassegna bibliografica. Rivista di Scienza dell'Alimentazione 29(4): 421-432
Groppali, R.; Guerci, P.; Pesarini, C. 1999: I ragni dell'Appennino settentrionale: Appunti sulle specie di Gusano di Gropparello (Piacenza) (ARACHNIDA, ARANEAE). Doriana 7(318): 1-12
Piacenza, L. 2001: I resti botanici del sito archeologico di Cahuachi (Nazca, Peru). Informatore Botanico Italiano 33(1): 51-55
Fratello, B.; Bertogna, I. 1999: I rettili Viperini della Collezione Franchini. Atti della Societa dei Naturalisti e Matematici di Modena 130: 143-179
Lo-Giudice, V.; Bruni, A.; Loizzo, M.; Perrone, L.; Perfetti, O.; Barbieri, A. 2001: I ricoveri in regime di D.H. in una Divisione di Pneumologia: Considerazioni su finalita e congruita. Igiene Moderna 115(5): 335-352
Lazzarin, G. 2000: I tipi nomenclaturali di A.B. Massalongo conservati nell'erbario lichenologico presso il Museo Civico di Storia Naturale di Verona. Bollettino del Museo Civico di Storia Naturale di Verona Botanica Zoologica 24: 45-106
Verni, E.; Cucca, G.; Ensini, A.; Blasi, A.; Romagnoli, M.; Giannini, S. 2002: I traumi in inversione della tibio/tarsica nello sportivo. Incidenza del morfotipo sulle recidive. Medicina dello Sport 55(1): 29-37
Poggioli, R.; Tartaglia, A.; Tiraferri, F.; Vezzadini, P. 1999: I tumori endocrini dell'apparato digerente a produzione di somatostatina. Rivista di Patologia e Clinica 54(1-2): 13-19
Biscotti, N. 2001: I valori Botanici del Gargano. Informatore Botanico Italiano 33(1): 289-291
Macrae, C.Neil.; Roseveare, T.A. 2002: I was always on my mind: The self and temporary forgetting. Psychonomic Bulletin and Review 9(3): 611-614
Sulmasy, D.P.; Rahn, M. 2001: I was sick and you came to visit me: Time spent at the bedsides of seriously ill patients with poor prognoses. American Journal of Medicine 111(5): 385-389
Bowman, R. 2002: I went; i saw: i was never the same!. British Journal of Ophthalmology 86(4): 370-371
Utsunomiya, K.; Narabayashi, I.; Nakatani, Y.; Tamura, K.; Onishi, S. 1999: I-123 MIBG cardiac imaging in diabetic neuropathy before and after epalrestat therapy. Clinical Nuclear Medicine 24(6): 418-420
Haensch, C.-A.; Jörg, J.; Lerch, H. 2002: I-123-metaiodobenzylguanidine uptake of the forearm shows dysfunction in peripheral sympathetic mediated neurovascular transmission in complex regional pain syndrome type i (CRPS I). Journal of Neurology 249(12): 1742-1743
Battermann, J.J. 2000: I-125 implantation for localized prostate cancer: The Utrecht University experience. RadioTherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 57(3): 269-272
Kurtek, R.W.; Tauxe, W.N.; Lai, K.K.; Fung, J.J. 1999: I-131 orthoiodohippurate assessment of renal function after heart transplantation. Clinical Nuclear Medicine 24(2): 117-119
Risse, J.H.; Grünwald, F.; Strunk, H.; Kleinschmidt, R.; Bender, H.; Biersack, H.J. 1999: I-131-Lipiodol therapy in liver neoplasms. Hybridoma 18(1): 83-85
Bernardini, G.; Spinetti, G.; Ribatti, D.; Camarda, G.; Morbidelli, L.; Ziche, M.; Santoni, A.; Capogrossi, M.C.; Napolitano, M. 2000: I-309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo. Blood 96(13): 4039-4045
Bayerlein, K.; Rith, T.; Verdorfer, I.; Liehr, T.; Wolff, E.; Girod, S.; Gebhart, E. 2000: I-FISH control of CGH-detected gain of DNA sequence copy number in oral squamous cell carcinomas (OSCC). Anticancer Research 20(1a): 427-432
Johannes, R.E.; Yeeting, B. 2001: I-Kiribati knowledge and management of Tarawa's lagoon resources. Atoll Research Bulletin (481-493): 489
Elde, M.; Haugen, P.; Willassen, N.P.; Johansen, S. 1999: I-NjaI, a nuclear intron-encoded homing endonuclease from Naegleria, generates a pentanucleotide 3' cleavage-overhang within a 19 base-pair partially symmetric DNA recognition site. European Journal of Biochemistry 259(1-2): 281-288
Kim, S.Jun.; Gershov, D.; Ma, X.; Brot, N.; Elkon, K.B. 2002: I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation. Journal of Experimental Medicine 196(5): 655-665
Kwon, H.Y.; Kim, Z.S. 2002: I-SSR variation within and among Korean populations in Taxus cuspidata. Journal of Korean Forestry Society 91(5): 654-660
Kabra, M.; Gulati, S.; Kaur, M.; Sharma, J.; Singh, A.; Chopra, V.; Menon, P.S.; Kalra, V. 2000: I-cell disease (Mucolipidosis II). Indian Journal of Pediatrics 67(9): 683-687
Müller, P.; Reichenbach, H.; Möckel, A.; Bührdel, P. 2000: I-cell disease complicated by unusual dilatative cardiomyopathy. Journal of Inherited Metabolic Disease 23(5): 514-516
Kusano, S.; Raab-Traub, N. 2002: I-mfa domain proteins interact with Axin and affect its regulation of the Wnt and c-Jun N-terminal kinase signaling pathways. Molecular and Cellular Biology 22(18): 6393-6405
Dahms, N..M.; Hancock, M.K. 2002: P-type lectins. Biochimica et Biophysica Acta 1572(2-3): 317-340
Mira, D.S.lva, L.; Park, J.R.; Keatinge, J.D.H.; Pinto, P.A. 2001: I. A decision support system to improve planning and management in large irrigation schemes. Agricultural Water Management 51(3): 187-201
O'neill, W.; O'boyle, J.; Harford, V.; Cooper, C.; Igoe, T.; Farrell, M.; Mckay, P. 2000: I. A profile of attenders at psychiatric outpatient clinics in Ireland's Eastern Health Board Region. Irish Journal of Psychological Medicine 17(1): 12-14
Adamali, H.I.; Somani, I.H.; Huang, J.Q.; Mahuran, D.; Gravel, R.A.; Trasler, J.M.; Hermo, L. 1999: I. Abnormalities in cells of the testis, efferent ducts, and epididymis in juvenile and adult mice with beta-hexosaminidase A and B deficiency. Journal of Andrology 20(6): 779-802
Wheeler, M.J.; Will, R.E.; Markewitz, D.; Jacobson, M.A.; Shirley, A.M. 2002: I. Early loblolly pine stand response to tillage on the Piedmont and Upper Coastal Plain of Georgia: Mortality, stand uniformity, and second and third year growth. Southern Journal of Applied Forestry 26(4): 181-189
Kautz, J.E.; Braun, C.E. 2000: I. Feasibility of estimating band-tailed pigeon population parameters using capture-recapture. Colorado Division of Wildlife Special Report 75: 1-14
Clark, K.F.; Farber, J.P. 2001: Internal superior laryngeal nerve afferent activity during respiration and evoked vocalization in cats. Annals of Otology Rhinology and Laryngology. Supplement 187: 3-17
Koenig, A.; Kirschner, S.; Walther, M.; Boehm, D.; Faller, H. 2000: I. Kulturelle Adaptation, Praktikabilitaets- und Reliabilitaetspruefung des Funktionsfragebogen Bewegungsapparat (SMFA-D). Zeitschrift fuer Orthopaedie und ihre Grenzgebiete 138(4): 295-301
Johnson, M.S.; Thomson, S.C.; Speakman, J.R. 2001: I. Lactation in the laboratory mouse Mus musculus. Journal of Experimental Biology 204(11): 1925-1935
Aon, M.A.; Cabello, M.N.; Sarena, D.E.; Colaneri, A.C.; Franco, M.G.; Burgos, J.L.; Cortassa, S. 2001: I. Spatio-temporal patterns of soil microbial and enzymatic activities in an agricultural soil. Applied Soil Ecology 18(3): 239-254
Chu, A.J.; Walton, M.A.; Seto, A.; Fox, M.J.; Prasad, J.K.; Wang, Z.G. 1999: I. Suppression by compound 48/80 of bacterial endotoxin-inducible monocytic tissue factor activity: Direct blockade of factor VII binding to THP-1 monocytes. Biochimica et Biophysica Acta 1472(1-2): 385-394
D.J.ger, C.; Bornman, M.S.; Van Der Horst, G. 1999: I. The effect of p-nonylphenol, an environmental toxicant with oestrogenic properties, on fertility potential in adult male rats. Andrologia 31(2): 99-106
Kaul, A.; Kalla, N.R.; Goyle, S. 2001: I. The modulatory effect in genotoxic responses due to age and duration of PHT-therapy in epileptic patients. Teratogenesis Carcinogenesis and Mutagenesis 21(2): 135-149
Lewis Smith, Ronald, I. 2000: I.M. Lamb's unpublished contribution to Antarctic lichenology. Nova Hedwigia 70(3-4): 491-504
Ben-Yehudah, A.; Prus, D.; Lorberboum-Galski, H. 2001: I.V. administration of L-GnRH-PE66 efficiently inhibits growth of colon adenocarcinoma xenografts in nude mice. International Journal of Cancer 92(2): 263-268
Salonen, A.; Kokki, H.; Tuovinen, K. 2001: I.v. ketoprofen for analgesia after tonsillectomy: comparison of pre- and post-operative administration. British Journal of Anaesthesia 86(3): 377-381
Lee, J.; Lovell, A.T.; Parry, M.G.; Glaisyer, H.R.; Bromley, L.M. 1999: I.v. clonidine: does it work as a hypotensive agent with inhalation anaesthesia?. British Journal of Anaesthesia 82(4): 639-640
Perttunen, K.; Nilsson, E.; Kalso, E. 1999: I.v. diclofenac and ketorolac for pain after thoracoscopic surgery. British Journal of Anaesthesia 82(2): 221-227
Hirota, K.; Hashimoto, Y.; Sato, T.; Yoshioka, H.; Kudo, T.; Ishihara, H.; Matsuki, A. 1999: I.v. lidocaine worsens histamine-induced bronchoconstriction in dogs. British Journal of Anaesthesia 82(1): 87-89
Serpell, M.G.; Anderson, E.; Wilson, D.; Dawson, N. 2000: I.v. regional diamorphine for analgesia after foot surgery. British Journal of Anaesthesia 84(1): 95-96
Hajek, D.; Tomiska, M.; Krahulcova, E.; Druckmuller, M.; Florianova, M.; Izakovicova-Holla, L.; Vacha, J. 2003: I/D ACE gene polymorphism in survival of leukemia patients -- hypothesis and pilot study. Medical Hypotheses 61(1): 80-85
Head, G.A.; Burke, S.L. 2000: I1 imidazoline receptors in cardiovascular regulation: The place of rilmenidine. American Journal of Hypertension 13(6 Pt 2): 89s-98s
Bousquet, P. 2001: I1 receptors, cardiovascular function, and metabolism. American Journal of Hypertension 14(11 Pt 2): 317s-321s
Wenzel, R.R.; Spieker, L.; Qui, S.; Shaw, S.; Lüscher, T.F.; Noll, G. 1998: I1-imidazoline agonist moxonidine decreases sympathetic nerve activity and blood pressure in hypertensives. Hypertension 32(6): 1022-1027
Jerónimo, C.; Varzim, Gça.; Henrique, R.; Oliveira, J.; Bento, M.José.; Silva, C.; Lopes, C.; Sidransky, D. 2002: I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 11(5): 445-450
Dardonville, C.; Rozas, I.; Callado, L.F.; Meana, J.Javier. 2002: I(2)-imidazoline binding site affinity of a structurally different type of ligands. Bioorganic and Medicinal Chemistry 10(5): 1525-1533
Ballesteros, J.; Maeztu, A.I.; Callado, L.F.; Gutiérrez, M.; García-Sevilla, J.A.; Meana, J.J. 2000: I2-imidazoline receptors and monoamine oxidase B enzyme sites in human brain: Covariation with age. Neuroscience Letters 288(2): 135-138
Cechinel Filho, V.; da Silva, K.L.; de Souza, M.M.; Oliveira, A.E.; Yunes, R.A.; Guimarães, C.L.; Verdi, L.G.; Simionatto, E.L.; Delle Monache, F. 2000: I3-naringenin-II8--4'OMe-eriodictyol: a new potential analgesic agent isolated from Rheedia gardneriana leaves. Zeitschrift für Naturforschung. C Journal of Biosciences 55(9-10): 820-823
Gao, F.; Maple, B.R.; Wu, S.M. 2000: I4AA-Sensitive chloride current contributes to the center light responses of bipolar cells in the tiger salamander retina. Journal of Neurophysiology 83(6): 3473-3482
Gustafsson, M.G.; Agard, D.A.; Sedat, J.W. 1999: I5M: 3D widefield light microscopy with better than 100 nm axial resolution. Journal of Microscopy 195(Pt 1): 10-16
Pelz, C.; Jander, J.; Rosenboom, H.; Hammer, M.; Menzel, R. 1999: IA in Kenyon cells of the mushroom body of honeybees resembles shaker currents: kinetics, modulation by K+, and simulation. Journal of Neurophysiology 81(4): 1749-1759
Decochez, K.; De Leeuw, I.H.; Keymeulen, B.; Mathieu, C.; Rottiers, R.; Weets, I.; Vandemeulebroucke, E.; Truyen, I.; Kaufman, L.; Schuit, F.C.; Pipeleers, D.G.; Gorus, F.K. 2002: IA-2 autoantibodies predict impending type i diabetes in siblings of patients. Diabetologia 45(12): 1658-1666
Reyes-De-La-Cruz, H.; Soriano-Bello, E.; Richards, A.; Aguilar, R.; Sanchez-De-Jimenez, E. 2002: IAA and dOGA induced (Ca2+)cyt elevation in maize (Zea mays L.) tissues, however they do not target the same signaling pathway. TIP Revista Especializada en Ciencias Quimico Biologicas 5(2): 76-81
Müller, A.; Weiler, E.W. 2000: IAA-synthase, an enzyme complex from Arabidopsis thaliana catalyzing the formation of indole-3-acetic acid from (S)-tryptophan. Biological Chemistry 381(8): 679-686
Ferrari, G.; Górczyńska, K.; Mimmo, R.; De Lazzari, C.; Clemente, F.; Tosti, G.; Guaragno, M. 2001: IABP assistance: a test bench for the analysis of its effects on ventricular energetics and hemodynamics. International Journal of Artificial Organs 24(5): 274-280
Mascarenhas, H.-Assuncao-Antonio; Ito, M.-Fumiko 1998: IAC/IAS-5: Soybean cultivar resistant to stem canker. Bragantia 57(2): 267-269
Hopper, R.D.; Steinhausler, F.; Ronca Battista, M. 1999: IAEA/EPA International climatic test program for integrating radon detectors. Health Physics 77(3): 303-308
Pinotti, J.A.; Drezzet, J. 1998: IAMANEH and the new concept of reproductive health. International Journal of Gynecology and Obstetrics 63(Suppl 1): S3-S12
Ditzel, M.; Meier, P. 2002: IAP degradation: Decisive blow or altruistic sacrifice?. Trends in Cell Biology 12(10): 449-452
Perrelet, D.; Ferri, A.; Mackenzie, A.E.; Smith, G.M.; Korneluk, R.G.; Liston, P.; Sagot, Y.; Terrado, J.; Monnier, D.; Kato, A.C. 2000: IAP family proteins delay motoneuron cell death in vivo. European Journal of Neuroscience 12(6): 2059-2067
Sanna, M.Germana.; da Silva Correia, J.; Ducrey, O.; Lee, J.; Nomoto, K.; Schrantz, N.; Deveraux, Q.L.; Ulevitch, R.J. 2002: IAP suppression of apoptosis involves distinct mechanisms: the TAK1/JNK1 signaling cascade and caspase inhibition. Molecular and Cellular Biology 22(6): 1754-1766
Tamm, I.; Wang, Y.; Sausville, E.; Scudiero, D.A.; Vigna, N.; Oltersdorf, T.; Reed, J.C. 1998: IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Research 58(23): 5315-5320
Smith, C.J.; Perfetti, T.A.; Garg, R.; Hansch, C. 2003: IARC carcinogens reported in cigarette mainstream smoke and their calculated log P values. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 41(6): 807-817
Mignen, O.; Shuttleworth, T.J. 2000: I(ARC), a novel arachidonate-regulated, noncapacitative Ca(2+) entry channel. Journal of Biological Chemistry 275(13): 9114-9119
Mosca, D.A.; Hurst, M.A.; So, W.; Viajar, B.S.; Fujii, C.A.; Falla, T.J. 2000: IB-367, a protegrin peptide with in vitro and in vivo activities against the microflora associated with oral mucositis. Antimicrobial Agents and ChemoTherapy 44(7): 1803-1808
Fernández-Chimeno, R.I.; Cañedo, L.; Espliego, F.; Grávalos, D.; De La Calle, F.; Fernández-Puentes, J.L.; Romero, F. 2000: IB-96212, a novel cytotoxic macrolide produced by a marine Micromonospora. I. Taxonomy, fermentation, isolation and biological activities. Journal of Antibiotics 53(5): 474-478
Cañedo, L.M.; Fernández-Puentes, J.L.; Baz, J.P. 2000: IB-96212, a novel cytotoxic macrolide produced by a marine Micromonospora. II. Physico-chemical properties and structure determination. Journal of Antibiotics 53(5): 479-483
Bonny, C.; Oberson, A.; Steinmann, M.; Schorderet, D.F.; Nicod, P.; Waeber, G. 2000: IB1 reduces cytokine-induced apoptosis of insulin-secreting cells. Journal of Biological Chemistry 275(22): 16466-16472
Borisova, E.V.; Tsarenko, P.M. 2002: IBASU-A, collection of Ukrainian microalgae cultures. Botanicheskii Zhurnal (St Petersburg) 87(5): 122-127
Giakkoupi, P.; Tzouvelekis, L.S.; Tsakris, A.; Loukova, V.; Sofianou, D.; Tzelepi, E. 2000: IBC-1, a novel integron-associated class a beta-lactamase with extended-spectrum properties produced by an Enterobacter cloacae clinical strain. Antimicrobial Agents and ChemoTherapy 44(9): 2247-2253
Hwang, H-Seo.; Song, K. 2002: IBD2 encodes a novel component of the Bub2p-dependent spindle checkpoint in the budding yeast Saccharomyces cerevisiae. Genetics 161(2): 595-609
Hyberts, S.G.; Wagner, G. 2003: IBIS--a tool for automated sequential assignment of protein spectra from triple resonance experiments. Journal of Biomolecular NMR 26(4): 335-344
Wallace, V.A.; Jensen, A.M. 1999: IBMX, taurine and 9-cis retinoic acid all act to accelerate rhodopsin expression in postmitotic cells. Experimental Eye Research 69(6): 617-627
Zhuang, Z.P.; Kung, M.P.; Hou, C.; Plössl, K.; Skovronsky, D.; Gur, T.L.; Trojanowski, J.Q.; Lee, V.M.; Kung, H.F. 2001: IBOX(2-(4'-dimethylaminophenyl)-6-iodobenzoxazole): A ligand for imaging amyloid plaques in the brain. Nuclear Medicine and Biology 28(8): 887-894
Rondinella, V.V.; Betti, M.; Bocci, F.; Hiernaut, T.; Cobos, J. 2000: IC-ICP-MS applied to the separation and determination of traces of plutonium and uranium in aqueous leachates and acid rinse solutions of UO2 doped with 238Pu. Microchemical Journal 67(1-3): 301-304
Axtelle, T.; Pribble, J. 2001: IC14, a CD14 specific monoclonal antibody, is a potential treatment for patients with severe sepsis. Journal of Endotoxin Research 7(4): 310-314
Iijima, M.; Someno, T.; Imada, C.; Okami, Y.; Ishizuka, M.; Takeuchi, T. 1999: IC202A, a new siderophore with immunosuppressive activity produced by Streptoalloteichus sp. 1454-19. I. Taxonomy, fermentation, isolation and biological activity. Journal of Antibiotics 52(1): 20-24
Iijima, M.; Someno, T.; Amemiya, M.; Sawa, R.; Naganawa, H.; Ishizuka, M.; Takeuchi, T. 1999: IC202A, a new siderophore with immunosuppressive activity produced by Streptoalloteichus sp. 1454-19. II. Physico-chemical properties and structure elucidation. Journal of Antibiotics 52(1): 25-28
Svensén, M.; Kruggel, F.; Benali, H. 2002: ICA of fMRI group study data. Neuroimage 16(3 Pt 1): 551-563
Greenbaum, C.J.; Gaur, L.K.; Noble, J.A. 2002: ICA+ relatives with DQA1*0102/DQB1*0602 have expected 0602 sequence and DR types. Journal of Autoimmunity 18(1): 67-70
Lampasona, V.; Scirpoli, M.; Bosi, E.; Bonifacio, E. 2001: ICA12(SOX13) autoantibodies are unlikely to be a useful marker for pre-clinical Type i diabetes. Diabetologia 44(2): 267
Miao, D.; Yu, L.; Tiberti, C.; Cuthbertson, D.D.; Rewers, M.; di Mario, U.; Eisenbarth, G.S.; Dotta, F. 2002: ICA512(IA-2) epitope specific assays distinguish transient from diabetes associated autoantibodies. Journal of Autoimmunity 18(2): 191-196
Sunami, T.; Yashiro, M.; Chung, K.H. 2000: ICAM-1 (intercellular adhesion molecule-1) gene transfection inhibits lymph node metastasis by human gastric cancer cells. Japanese Journal of Cancer Research: Gann 91(9): 925-933
Poston, R.S.; Ing, D.J.; Ennen, M.P.; Hoyt, E.G.; Robbins, R.C. 1999: ICAM-1 affects reperfusion injury and graft function after cardiac transplantation. Journal of Surgical Research 87(1): 25-31
Deeths, M.J.; Mescher, M.F. 1999: ICAM-1 and B7-1 provide similar but distinct costimulation for CD8+ T cells, while CD4+ T cells are poorly costimulated by ICAM-1. European Journal of Immunology 29(1): 45-53
Zeni, F.; Parent, C.; Correa, R.; Natanson, C.; Freeman, B.; Fontana, J.; Quezado, M.; Danner, R.L.; Fitz, Y.; Richmond, S.; Gerstenberger, E.; Banks, S.M.; Eichacker, P.Q. 1999: ICAM-1 and CD11b inhibition worsen outcome in rats with E. coli pneumonia. Journal of Applied Physiology 87(1): 299-307
Rijcken, E.; Krieglstein, C.F.; Anthoni, C.; Laukoetter, M.G.; Mennigen, R.; Spiegel, H.U.; Senninger, N.; Bennett, C.F.; Schuermann, G. 2002: ICAM-1 and VCAM-1 antisense oligonucleotides attenuate in vivo leucocyte adherence and inflammation in rat inflammatory bowel disease. Gut 51(4): 529-535
Van der Zijpp, Y.J.T.; Poot, A.A.; Feijen, J. 2003: ICAM-1 and VCAM-1 expression by endothelial cells grown on fibronectin-coated TCPS and PS. Journal of Biomedical Materials Research. Part a 65(1): 51-59
Vignola, A.M.; Bonsignore, G.; Siena, L.; Melis, M.; Chiappara, G.; Gagliardo, R.; Bousquet, J.; Bonsignore, G.; Merendino, A.M. 2000: ICAM-1 and alpha3beta1 expression by bronchial epithelial cells and their in vitro modulation by inflammatory and anti-inflammatory mediators. Allergy 55(10): 931-939
Haritopoulos, K.N.; Lazaris, A.C.; Kavantzas, N.; Tseleni-Balafouta, S.; Thomopoulou, G.; Aroni, K. 2003: ICAM-1 and beta(3) integrin immunoexpression in malignant melanoma cells: can they be used as additional predictors?. Apmis: Acta Pathologica Microbiologica et Immunologica Scandinavica 111(3): 421-429
Chen, T.; Goldstein, J.S.; O'boyle, K.; Whitman, M.C.; Brunswick, M.; Kozlowski, S. 1999: ICAM-1 co-stimulation has differential effects on the activation of CD4+ and CD8+ T cells. European Journal of Immunology 29(3): 809-814
Goldstein, J.S.; Chen, T.; Gubina, E.; Pastor, R.W.; Kozlowski, S. 2000: ICAM-1 enhances MHC-peptide activation of CD8(+) T cells without an organized immunological synapse. European Journal of Immunology 30(11): 3266-3270
De Greef, K.E.; Ysebaert, D.K.; Persy, V.; Vercauteren, S.R.; De Broe, M.E. 2003: ICAM-1 expression and leukocyte accumulation in inner stripe of outer medulla in early phase of ischemic compared to HgCl2-induced ARF. Kidney International 63(5): 1697-1707
Maruo, Y.; Gochi, A.; Kaihara, A.; Shimamura, H.; Yamada, T.; Tanaka, N.; Orita, K. 2002: ICAM-1 expression and the soluble ICAM-1 level for evaluating the metastatic potential of gastric cancer. International Journal of Cancer 100(4): 486-490
Rolfe, B.E.; Muddiman, J.D.; Smith, N.J.; Campbell, G.R.; Campbell, J.H. 2000: ICAM-1 expression by vascular smooth muscle cells is phenotype-dependent. Atherosclerosis 149(1): 99-110
Sipkins, D.A.; Gijbels, K.; Tropper, F.D.; Bednarski, M.; Li, K.C.; Steinman, L. 2000: ICAM-1 expression in autoimmune encephalitis visualized using magnetic resonance imaging. Journal of Neuroimmunology 104(1): 1-9
Song, X.Y.; Zeng, Y.J.; Li, C.X.; Liao, D.H.; Hu, J.L.; Hao, Y.L. 2001: ICAM-1 expression of rat brain microvascular endothelial cells caused by fluid shear force. Sheng Li Xue Bao: 53(1): 13-17
Martin, C.Marcos.; Santos Lacomba, M.; Serrano Molina, C.Ignacio.; Ramirez Chamond, R.; Collantes Estevez, E. 2002: ICAM-1 expression on the surface of T lymphocytes in patients with uveitis: a comparative study between the eye and peripheral blood. Ophthalmologica. Journal International D'ophtalmologie. International Journal of Ophthalmology. Zeitschrift für Augenheilkunde 216(3): 203-208
Marrosu, M.G.; Schirru, L.; Fadda, E.; Mancosu, C.; Lai, M.; Cocco, E.; Cucca, F. 2000: ICAM-1 gene is not associated with multiple sclerosis in sardinian patients. Journal of Neurology 247(9): 677-680
Baviera, G.; D'Anna, R.; Corrado, F.; Ruello, A.; Buemi, M.; Jasonni, V.Maria. 2002: ICAM-1 in maternal serum and amniotic fluid as an early marker of preeclampsia and IUGR. Journal of Reproductive Medicine 47(3): 191-193
Clayton, A.; Steadman, R. 1999: ICAM-1 interactions in the renal interstitium: a novel activator of fibroblasts during nephritis. Histology and Histopathology 14(3): 861-870
Drescher, K.M.; Zoecklein, L.J.; Rodriguez, M. 2002: ICAM-1 is crucial for protection from TMEV-induced neuronal damage but not demyelination. Journal of Neurovirology 8(5): 452-458
Noisakran, S.; Härle, P.; Carr, D.J. 2001: ICAM-1 is required for resistance to herpes simplex virus type 1 but not interferon-alpha1 transgene efficacy. Virology 283(1): 69-77
Robledo, O.; Papaioannou, A.; Ochietti, B.; Beauchemin, C.; Legault, D.; Cantin, A.é; King, P.D.; Daniel, C.; Alakhov, V.Y.; Potworowski, E.F.; St-Pierre, Y. 2003: ICAM-1 isoforms: specific activity and sensitivity to cleavage by leukocyte elastase and cathepsin G. European Journal of Immunology 33(5): 1351-1360
Selzner, N.; Selzner, M.; Odermatt, B.; Tian, Y.; Van Rooijen, N.; Clavien, P-Alain. 2003: ICAM-1 triggers liver regeneration through leukocyte recruitment and Kupffer cell-dependent release of TNF-alpha/IL-6 in mice. Gastroenterology 124(3): 692-700
Berney, S.M.; Schaan, T.; Alexander, J.S.; Peterman, G.; Hoffman, P.A.; Wolf, R.E.; van der Heyde, H.; Atkinson, T.P. 1999: ICAM-3 (CD50) cross-linking augments signaling in CD3-activated peripheral human T lymphocytes. Journal of Leukocyte Biology 65(6): 867-874
Verkarre, V.; Patey-Mariaud de Serre, N.; Vazeux, R.; Teillac-Hamel, D.; Chretien-Marquet, B.; Le Bihan, C.; Leborgne, M.; Fraitag, S.; Brousse, N. 1999: ICAM-3 and E-selectin endothelial cell expression differentiate two phases of angiogenesis in infantile hemangiomas. Journal of Cutaneous Pathology 26(1): 17-24
Chiang, S.Chi.; Chang, S.Ching.; Lee, S.Tone. 2002: ICAM-L gene is conserved only in Leishmania species in the family of kinetoplastida. Molecular and Biochemical Parasitology 124(1-2): 47-50
Murciano, J.-C.; Muro, S.; Koniaris, L.; Christofidou-Solomidou, M.; Harshaw, D.W.; Albelda, S.M.; Granger, D.N.; Cines, D.B.; Muzykantov, V.R. 2003: ICAM-directed vascular immunotargeting of antithrombotic agents to the endothelial luminal surface. Blood 101(10): 3977-3984
Daniels, D.L.; Weis, W.I. 2002: ICAT inhibits beta-catenin binding to Tcf/Lef-family transcription factors and the general coactivator p300 using independent structural modules. Molecular Cell 10(3): 573-584
Hopfner, R.; Mousli, M.; Jeltsch, J.M.; Voulgaris, A.; Lutz, Y.; Marin, C.; Bellocq, J.P.; Oudet, P.; Bronner, C. 2000: ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIalpha expression. Cancer Research 60(1): 121-128
Summerfield, D. 2002: ICD and DSM are contemporary cultural documents. Bmj 324(7342): 914
Deb, S. 1999: ICD-10 codes detect only a proportion of all head injury admissions. Brain Injury 13(5): 369-373
Pedersen, S.H.; Stage, K.B.; Bertelsen, A.; Grinsted, P.; Kragh-Sørensen, P.; Sørensen, T. 2001: ICD-10 criteria for depression in general practice. Journal of Affective Disorders 65(2): 191-194
Humke, E.W.; Shriver, S.K.; Starovasnik, M.A.; Fairbrother, W.J.; Dixit, V.M. 2000: ICEBERG: a novel inhibitor of interleukin-1beta generation. Cell 103(1): 99-111
Mémin, E.; Yehia, G.; Razavi, R.; Molina, C.A. 2002: ICER reverses tumorigenesis of rat prostate tumor cells without affecting cell growth. Prostate 53(3): 225-231
Razavi, R.; Ramos, J.C.; Yehia, G.; Schlotter, F.; Molina, C.A. 1998: ICER-IIgamma is a tumor suppressor that mediates the antiproliferative activity of cAMP. Oncogene 17(23): 3015-3019
Sussman, M.A. 2003: ICER-capades: putting cardiac cyclic AMP signaling "on ice". Circulation Research 93(1): 6-8
Usui, Y. 2001: ICG dye enhanced diode laser therapy for hemorrhoids: A new procedure. Journal of the Japan Society of Coloproctology 54(10): 921-925
Okochi, O.; Kaneko, T.; Sugimoto, H.; Inoue, S.; Takeda, S.; Nakao, A. 2002: ICG pulse spectrophotometry for perioperative liver function in hepatectomy. Journal of Surgical Research 103(1): 109-113
Donati, G.; Kapetanios, A.D.; Pournaras, C.J. 1999: ICG-guided laser photocoagulation of juxtafoveal and extrafoveal occult choroidal neovascularization. Graefe's Archive for Clinical and Experimental Ophthalmology 237(11): 881-886
Phillips, A.; Haudiquet, V. 2003: ICH E9 guideline 'Statistical principles for clinical trials': a case study. Statistics in Medicine 22(1): 1-11; Discussion: 13-17
Bode, G.; Olejniczak, K. 2002: ICH topic: The draft ICH S7B step 2: Note for guidance on Safety Pharmacology Studies for Human Pharmaceuticals. Fundamental and Clinical Pharmacology 16(2): 105-118
Müller, L.; Kikuchi, Y.; Probst, G.; Schechtman, L.; Shimada, H.; Sofuni, T.; Tweats, D. 1999: ICH-harmonised guidances on genotoxicity testing of pharmaceuticals: Evolution, reasoning and impact. Mutation Research 436(3): 195-225
Robertson, J.F.R. 2001: ICI 182,780 (FulvestrantTM): The first oestrogen receptor down-regulator: Current clinical data. British Journal of Cancer 85(Suppl 2): 11-14
Robertson, J.A.; Zhang, Y.; Ing, N.H. 2001: ICI 182,780 acts as a partial agonist and antagonist of estradiol effects in specific cells of the sheep uterus. Journal of Steroid Biochemistry and Molecular Biology 77(4-5): 281-287
Hanazono, M.; Moro, K.; Nakagawa, E.; Tomooka, Y. 1998: ICI 182,780 stimulates the growth of a uterine cell line derived from p53-deficient mice. Zoological Science 15(5): 737-740
Hershko, C.; Konijn, A.M.; Nick, H.P.; Breuer, W.; Cabantchik, Z.I.; Link, G. 2001: ICL670A: a new synthetic oral chelator: evaluation in hypertransfused rats with selective radioiron probes of hepatocellular and reticuloendothelial iron stores and in iron-loaded rat heart cells in culture. Blood 97(4): 1115-1122
Fernández-Recio, J.; Totrov, M.; Abagyan, R. 2003: ICM-DISCO docking by global energy optimization with fully flexible side-chains. Proteins 52(1): 113-117
Icon-Collaborators 1998: ICON2: Randomised trial of single-agent carboplatin against three-drug combination of CAP (cyclophosphamide, doxorubicin, and cisplatin) in women with ovarian cancer. Lancet (North American Edition) 352(9140): 1571-1576
Witsch, E.J.; Peiser, M.; Hutloff, A.; Büchner, K.; Dorner, B.G.; Jonuleit, H.; Mages, H.W.; Kroczek, R.A. 2002: ICOS and CD28 reversely regulate IL-10 on re-activation of human effector T cells with mature dendritic cells. European Journal of Immunology 32(9): 2680-2686
Kanai, T.; Totsuka, T.; Tezuka, K.; Watanabe, M. 2002: ICOS costimulation in inflammatory bowel disease. Journal of Gastroenterology 37(Suppl 14): 78-81
Sporici, R.A.; Beswick, R.L.; von Allmen, C.; Rumbley, C.A.; Hayden-Ledbetter, M.; Ledbetter, J.A.; Perrin, P.J. 2001: ICOS ligand costimulation is required for T-cell encephalitogenicity. Clinical Immunology 100(3): 277-288
Bonhagen, K.; Liesenfeld, O.; Stadecker, M.J.; Hutloff, A.; Erb, K.; Coyle, A.J.; Lipp, M.; Kroczek, R.A.; Kamradt, T. 2003: ICOS+ Th cells produce distinct cytokines in different mucosal immune responses. European Journal of Immunology 33(2): 392-401
Morgalla, M.H.; Mettenleiter, H.; Katzenberger, T. 1999: ICP measurement accuracy: the effect of temperature drift. Design of a laboratory test for assessment of ICP transducers. Journal of Medical Engineering and Technology 23(1): 10-14
Morgalla, M.H.; Mettenleiter, H.; Bitzer, M.; Fretschner, R.; Grote, E.H. 1999: ICP measurement control: laboratory test of 7 types of intracranial pressure transducers. Journal of Medical Engineering and Technology 23(4): 144-151
Zwienenberg, M.; Gong, Q.Z.; Lee, L.L.; Berman, R.F.; Lyeth, B.G. 1999: ICP monitoring in the rat: Comparison of monitoring in the ventricle, brain parenchyma, and cisterna magna. Journal of Neurotrauma 16(11): 1095-1102
Kvaeven, B.; Ulstein, M., J.; Skjelkvale, B., L.; Raddum, G., G.; Hovind, H. 2001: ICP waters: An international programme for surface water monitoring. Water Air and Soil Pollution 130(1-4 Part 2): 775-780
Caroli, S.; Forte, G.; Iamiceli, A.L. 1999: ICP-AES and ICP-MS quantification of trace elements in the marine macroalga Fucus sample, a new candidate Certified Reference Material. Microchemical Journal 62(2): 244-250
Gong, B.; Wang, Y. 2002: ICP-AES determination of traces of noble metal ions pre-concentrated and separated on a new polyacrylacylaminothiourea chelating fiber. Analytical and Bioanalytical Chemistry 372(4): 597-600
Wei Zhenggui; Wan Shoukang; Zhang Xun; Hong Fashui; Zhao Guiwen; Tao Ye 2001: ICP-AES studies on characteristics of distribution, accumulation and transportation of rare earth elements in soil-Dicranopteris dichotoma system. Yingyong Shengtai Xuebao 12(6): 863-866
Tagami, K.; Uchida, S. 2001: ICP-MS determination of Re at ultra trace levels in rock and soil samples. Journal of Analytical Atomic Spectrometry 16(6): 669-671
Almeida, C.M.; Vasconcelos, M.T. S.D. 2001: ICP-MS determination of strontium isotope ratio in wine in order to be used as a fingerprint of its regional origin. Journal of Analytical Atomic Spectrometry 16(6): 607-611
Tubaro, F.; Barbangelo, F.; Toniolo, R.; Di Narda, F.; Susmel, S.; Bontempelli, G. 2002: ICP-MS determination of toxic-metal release from pumping systems for food processing. Annali di Chimica 92(3): 289-299
St'astna, M.; Nemcova, I.; Zyka, J. 1999: ICP-MS for the determination of trace elements in clinical samples. Analytical Letters 32(13): 2531-2543
Almeida, C.M.R.; Vasconcelos, M.T.S.D.; Barbaste, M.; Medina, B. 2002: ICP-MS multi-element analysis of wine samples - a comparative study of the methodologies used in two laboratories. Analytical and Bioanalytical Chemistry 374(2): 314-322
Vandecasteele, C.; Van-Den-Broeck, K.; Dutre, V. 2000: ICP-MS, hydride generation-ICP-MS, and CZE for the study (analysis and speciation) of solidification/stabilisation of industrial waste containing arsenic. Waste Management 20(2-3): 211-216
Zhang, C.; Wu, F.; Zhang, X. 2002: ICP-MS-based competitive immunoassay for the determination of total thyroxin in human serum. Journal of Analytical Atomic Spectrometry 17(10): 1304-1307
Vanhaecke, F. 2002: ICP-MS. Alternative means for the elimination of interferences. Analytical and Bioanalytical Chemistry 372(1): 20-21
Wyse, E.J.; Lee, S.H.; La-Rosa, J.; Povinec, P.; De-Mora, S.J. 2001: ICP-sector field mass spectrometry analysis of plutonium isotopes: Recognizing and resolving potential interferences. Journal of Analytical Atomic Spectrometry 16(9): 1107-1111
Everett, R.D. 2000: ICP0 induces the accumulation of colocalizing conjugated ubiquitin. Journal of Virology 74(21): 9994-10005
Halford, W.P.; Schaffer, P.A. 2001: ICP0 is required for efficient reactivation of herpes simplex virus type 1 from neuronal latency. Journal of Virology 75(7): 3240-3249
Halford, W.P.; Kemp, C.D.; Isler, J.A.; Davido, D.J.; Schaffer, P.A. 2001: ICP0, ICP4, or VP16 expressed from adenovirus vectors induces reactivation of latent herpes simplex virus type 1 in primary cultures of latently infected trigeminal ganglion cells. Journal of Virology 75(13): 6143-6153
Long, M.C.; Leong, V.; Schaffer, P.A.; Spencer, C.A.; Rice, S.A. 1999: ICP22 and the UL13 protein kinase are both required for herpes simplex virus-induced modification of the large subunit of RNA polymerase Ii. Journal of Virology 73(7): 5593-5604
Sciabica, K.S.; Dai, Q.J.; Sandri-Goldin, R.M. 2003: ICP27 interacts with SRPK1 to mediate HSV splicing inhibition by altering SR protein phosphorylation. EMBO Journal 22(7): 1608-1619
Chen, I-Hsiung.Brandon.; Sciabica, K.S.; Sandri-Goldin, R.M. 2002: ICP27 interacts with the RNA export factor Aly/REF to direct herpes simplex virus type 1 intronless mRNAs to the TAP export pathway. Journal of Virology 76(24): 12877-12889
Atherholt, T.B.; Korn, L.R. 1999: ICR protocol: Alternative treatment of parasite sample data: Alternative data analysis and reporting methods may help avoid flaws inherent in the current ICR protocol. Journal - American Water Works Association 91(3): 95-102
Allgeier, S.C.; Shukairy, H.M.; Westrick, J.J. 1998: ICR treatment studies. Journal - American Water Works Association 90(11): 70-82
Hossain, M.S.; Akimitsu, N.; Takaki, T.; Hirai, H.; Sekimizu, K. 2002: ICRF-193, a catalytic inhibitor of DNA topoisomerase II, inhibits re-entry into the cell division cycle from quiescent state in mammalian cells. Genes to Cells: Devoted to Molecular and Cellular Mechanisms 7(3): 285-294
Saito, T.; Yamagata, T.; Takahashi, T.; Honda, H.; Hirai, H. 1999: ICSAT overexpression is not sufficient to cause adult T-cell leukemia or multiple myeloma. Biochemical and Biophysical Research Communications 260(2): 329-331
Tamura, T.; Nagamura-Inoue, T.; Shmeltzer, Z.; Kuwata, T.; Ozato, K. 2000: ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages. Immunity 13(2): 155-165
Schiavoni, G.; Mattei, F.; Sestili, P.; Borghi, P.; Venditti, M.; Morse, H.C.; Belardelli, F.; Gabriele, L. 2002: ICSBP is essential for the development of mouse type i interferon-producing cells and for the generation and activation of CD8alpha(+) dendritic cells. Journal of Experimental Medicine 196(11): 1415-1425
Levi, B-Zion.; Hashmueli, S.; Gleit-Kielmanowicz, M.; Azriel, A.; Meraro, D. 2002: ICSBP/IRF-8 transactivation: a tale of protein-protein interaction. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 22(1): 153-160
Tamura, T.; Ozato, K. 2002: ICSBP/IRF-8: its regulatory roles in the development of myeloid cells. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 22(1): 145-152
Ma, S.; Yuen, B.Ho.; Penaherrera, M.; Koehn, D.; Ness, L.; Robinson, W. 2003: ICSI and the transmission of X-autosomal translocation: a three-generation evaluation of X;20 translocation: case report. Human Reproduction 18(7): 1377-1382
Check, M.L.; Check, J.H.; Katsoff, D.; Summers-Chase, D. 2000: ICSI as an effective therapy for male factor with antisperm antibodies. Archives of Andrology 45(3): 125-130
Ramalho-Santos, J.; Sutovsky, P.; Simerly, C.; Oko, R.; Wessel, G.M.; Hewitson, L.; Schatten, G. 2000: ICSI choreography: Fate of sperm structures after monospermic rhesus ICSI and first cell cycle implications. Human Reproduction 15(12): 2610-2620
Kurokawa, M.; Fissore, R.A. 2003: ICSI-generated mouse zygotes exhibit altered calcium oscillations, inositol 1,4,5-trisphosphate receptor-1 down-regulation, and embryo development. Molecular Human Reproduction 9(9): 523-533
Tournaye, H. 2003: ICSI: A technique too far?. International Journal of Andrology 26(2): 63-69
Pereira, A.G.; Rinaudo, J.D.; Jeffrey, P.; Blasques, J.; Quintana, S.C.; Courtois, N.; Funtowicz, S.; Petit, V. 2003: ICT tools to support public participation in water resources governance & planning: Experiences from the design and testing of a Multi-Media platform. Journal of Environmental Assessment Policy and Management 5(3): 395-420
Ketzler, J.T.; McSweeney, M.E.; Coursin, D.B. 2002: ICU echocardiography: should we use it in a heart beat?. Chest 122(4): 1121-1123
Howard, L. 2002: ICU outcomes in acute respiratory failure secondary to COPD. Thorax 57(12): 1089
Chen-Izu, Y.; Sha, Q.; Shorofsky, S.R.; Robinson, S.W.; Wier, W.G.; Goldman, L.; Balke, C.W. 2001: I(Ca(TTX)) channels are distinct from those generating the classical cardiac Na(+) current. Biophysical Journal 81(5): 2647-2659
Garavaglia, M.L.; Rodighiero, S.; Bertocchi, C.; Manfredi, R.; Fürst, J.; Gschwentner, M.; Ritter, M.; Bazzini, C.; Bottà, G.; Jakab, M.; Meyer, G.; Paulmichl, M. 2002: ICln channels reconstituted in heart-lipid bilayer are selective to chloride. Pflugers Archiv: European Journal of Physiology 443(5-6): 748-753
Fürst, J.; Ritter, M.; Rudzki, J.; Danzl, J.; Gschwentner, M.; Scandella, E.; Jakab, M.; König, M.; Oehl, B.; Lang, F.; Deetjen, P.; Paulmichl, M. 2002: ICln ion channel splice variants in Caenorhabditis elegans: voltage dependence and interaction with an operon partner protein. Journal of Biological Chemistry 277(6): 4435-4445
Gschwentner, M.; Fürst, J.; Ritter, M.; Bazzini, C.; Wöll, E.; Dienstl, A.; Jakab, M.; König, M.; Scandella, E.; Rudzki, J.; Botta, G.; Meyer, G.; Lang, F.; Deetjen, P.; Paulmichl, M. 1999: ICln, an ion channel-forming protein associated with cell volume regulation. Experimental Physiology 84(6): 1023-1031
Houldsworth, J.; Reuter, V.E.; Bosl, G.J.; Chaganti, R.S. 2001: ID gene expression varies with lineage during differentiation of pluripotential male germ cell tumor cell lines. Cell and Tissue Research 303(3): 371-379
Norton, J.D. 2000: ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. Journal of Cell Science 113: 3897-3905
Wang, Q.; Hii, G.; Shusterman, S.; Mosse, Y.; Winter, C.L.; Guo, C.; Zhao, H.; Rappaport, E.; Hogarty, M.D.; Maris, J.M. 2003: ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas. Cancer Research 63(7): 1631-1635
Esfarjani, F.; Azar, M.R.; Gafarpour, M. 2001: IDDM and early exposure of infant to cow's milk and solid food. Indian Journal of Pediatrics 68(2): 107-110
Ishikawa, T.; Sobajima, H.; Aoki, T.; Suzuki, A.; Oba, M.; Watanabe, Y.; Suzuki, K.; Sassa, H.; Kumada, T.; Nakano, S. 2000: IDDM induced by interferon therapy with increase of anti-GAD antibody; A case report. Journal of the Japan Diabetes Society 43(4): 319-324
Walter, M.; Albert, E.; Conrad, M.; Keller, E.; Hummel, M.; Ferber, K.; Barratt, B.J.; Todd, J.A.; Ziegler, A.-G.; Bonifacio, E. 2003: IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of Type 1 diabetes and associated autoimmunity. Diabetologia 46(5): 712-720
Paterson, A.D.; Rahman, P.; Petronis, A. 1999: IDDM9 and a locus for rheumatoid arthritis on chromosome 3q appear to be distinct. Human Immunology 60(9): 883-885
Ribó, O.; Korn, C.; Meloni, U.; Cropper, M.; De Winne, P.; Cuypers, M. 2001: IDEA: a large-scale project on electronic identification of livestock. Revue Scientifique et Technique 20(2): 426-436
Feuring-Buske, M.; Kneba, M.; Unterhalt, M.; Engert, A.; Gramatzki, M.; Hiller, E.; Trümper, L.; Brugger, W.; Ostermann, H.; Atzpodien, J.; Hallek, M.; Aulitzky, E.; Hiddemann, W. 2000: IDEC-C2B8 (Rituximab) anti-CD20 antibody treatment in relapsed advanced-stage follicular lymphomas: Results of a phase-II study of the German Low-Grade Lymphoma Study Group. Annals of Hematology 79(9): 493-500
Nguyen, D.T.; Amess, J.A.; Doughty, H.; Hendry, L.; Diamond, L.W. 1999: IDEC-C2B8 anti-CD20 (Rituximab) immunotherapy in patients with low-grade non-Hodgkin's lymphoma and lymphoproliferative disorders: Evaluation of response on 48 patients. European Journal of Haematology 62(2): 76-82
Romualdi, C.; Bortoluzzi, S.; D'Alessi, F.; Danieli, G.A. 2003: IDEG6: a web tool for detection of differentially expressed genes in multiple tag sampling experiments. Physiological Genomics 12(2): 159-162
Le Bozec, C.; Jaulent, M.C.; Zapletal, E.; Heudes, D.; Degoulet, P. 1998: IDEM: A Web application of case-based reasoning in histopathology. Computers in Biology and Medicine 28(5): 473-487
Maeno, Y.; Kashiwagi, A.; Nishio, Y.; Takahara, N.; Kikkawa, R. 2000: IDL can stimulate atherogenic gene expression in cultured human vascular endothelial cells. Diabetes Research and Clinical Practice 48(2): 127-138
Taraboletti, G.; Micheletti, G.; Giavazzi, R.; Riva, A. 2003: IDN 5390: a new concept in taxane development. Anti-Cancer Drugs 14(4): 255-258
Nicoletti, M.I.; Colombo, T.; Rossi, C.; Monardo, C.; Stura, S.; Zucchetti, M.; Riva, A.; Morazzoni, P.; Donati, M.B.; Bombardelli, E.; D'Incalci, M.; Giavazzi, R. 2000: IDN5109, a taxane with oral bioavailability and potent antitumor activity. Cancer Research 60(4): 842-846
Grant, R.S.; Naif, H.; Espinosa, M.; Kapoor, V. 2000: IDO induction in IFN-gamma activated astroglia: a role in improving cell viability during oxidative stress. Redox Report: Communications in Free Radical Research 5(2-3): 101-104
Wakata, N.; Araki, Y.; Sugimoto, H.; Iguchi, H.; Kinoshita, M. 2000: IDPN-induced monoamine and hydroxyl radical changes in the rat brain. Neurochemical Research 25(3): 401-404
Fontana, M.R.; Monaci, E.; Yanqing, L.; Guoming, Q.; Duan, G.; Rappuoli, R.; Pizza, M. 2000: IEM101, a naturally attenuated Vibrio cholerae strain as carrier for genetically detoxified derivatives of cholera toxin. Vaccine 19(1): 75-85
Garcia, J.; Ye, Y.; Arranz, Vérie.; Letourneux, C.; Pezeron, G.; Porteu, Fçoise. 2002: IEX-1: A new ERK substrate involved in both ERK survival activity and ERK activation. EMBO Journal 21(19): 5151-5163
Murakami, H.; Liotta, L.; Star, R.A. 2000: IF-LCM: laser capture microdissection of immunofluorescently defined cells for mRNA analysis rapid communication. Kidney International 58(3): 1346-1353
Bakker, A.J.; Mirchi, B.; Dijkstra, J.T.; Reitsma, F.; Syperda, H.; Zijlstra, A. 2003: IFCC method for lactate dehydrogenase measurement in heparin plasma is unreliable. Clinical Chemistry 49(4): 662-664
Burnett, R.W.; D'Orazio, P.; Fogh-Andersen, N.; Kuwa, K.; Külpmann, W.R.; Larsson, L.; Lewnstam, A.; Maas, A.H.; Mager, G.; Spichiger-Keller, U. 2001: IFCC recommendation on reporting results for blood glucose. Clinica Chimica Acta; International Journal of Clinical Chemistry 307(1-2): 205-209
Burnett, R.W.; Christiansen, T.F.; Covington, A.K.; Fogh-Andersen, N.; Külpmann, W.R.; Lewenstam, A.; Maas AHJ; Müller-Plathe, O.; Sachs, C.; Andersen, O.S.; VanKessel, A.L.; Zijlstra, W.G. 2000: IFCC recommended reference method for the determination of the substance concentration of ionized calcium in undiluted serum, plasma or whole blood. Clinical Chemistry and Laboratory Medicine 38(12): 1301-1314
A.R.wi, K.R.; Casanova, J.L.; Romo, A. 2001: IFEMS: A new approach for monitoring wildfire evolution with NOAA-AVHRR imagery. International Journal of Remote Sensing 22(10): 2033-2042, 10 July
Zhong, R.; Ye, Z.H. 1999: IFL1, a gene regulating interfascicular fiber differentiation in Arabidopsis, encodes a homeodomain-leucine zipper protein. Plant Cell 11(11): 2139-2152
Contursi, C.; Wang, I.M.; Gabriele, L.; Gadina, M.; O'Shea, J.; Morse, H.C.; Ozato, K. 2000: IFN consensus sequence binding protein potentiates STAT1-dependent activation of IFNgamma-responsive promoters in macrophages. Proceedings of the National Academy of Sciences of the United States of America 97(1): 91-96
Tsujimura, H.; Nagamura-Inoue, T.; Tamura, T.; Ozato, K. 2002: IFN consensus sequence binding protein/IFN regulatory factor-8 guides bone marrow progenitor cells toward the macrophage lineage. Journal of Immunology 169(3): 1261-1269
Mariner, J.M.; Mamane, Y.; Hiscott, J.; Waldmann, T.A.; Azimi, N. 2002: IFN regulatory factor 4 participates in the human T cell lymphotropic virus type I-mediated activation of the IL-15 receptor alpha promoter. Journal of Immunology 168(11): 5667-5674
Storm van's Gravesande, K.; Layne, M.D.; Ye, Q.; Le, L.; Baron, R.M.; Perrella, M.A.; Santambrogio, L.; Silverman, E.S.; Riese, R.J. 2002: IFN regulatory factor-1 regulates IFN-gamma-dependent cathepsin S expression. Journal of Immunology 168(9): 4488-4494
Fantuzzi, L.; Puddu, P.; Varano, B.; Del Cornò, M.; Belardelli, F.; Gessani, S. 2000: IFN-alpha and IL-18 exert opposite regulatory effects on the IL-12 receptor expression and IL-12-induced IFN-gamma production in mouse macrophages: novel pathways in the regulation of the inflammatory response of macrophages. Journal of Leukocyte Biology 68(5): 707-714
Matikainen, S.; Paananen, A.; Miettinen, M.; Kurimoto, M.; Timonen, T.; Julkunen, I.; Sareneva, T. 2001: IFN-alpha and IL-18 synergistically enhance IFN-gamma production in human NK cells: differential regulation of Stat4 activation and IFN-gamma gene expression by IFN-alpha and IL-12. European Journal of Immunology 31(7): 2236-2245
Bode, J.G.; Ludwig, S.; Ehrhardt, C.; Albrecht, U.; Erhardt, A.; Schaper, F.; Heinrich, P.C.; Häussinger, D. 2003: IFN-alpha antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3. FASEB Journal 17(3): 488-490
Ross, C.; Engler, C.B.ød.; Sander, B.; Bendtzen, K. 2002: IFN-alpha antibodies in patients with age-related macular degeneration treated with recombinant human IFN-alpha2a. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 22(4): 421-426
Luft, T.; Luetjens, P.; Hochrein, H.; Toy, T.; Masterman, K-Anne.; Rizkalla, M.; Maliszewski, C.; Shortman, K.; Cebon, J.; Maraskovsky, E. 2002: IFN-alpha enhances CD40 ligand-mediated activation of immature monocyte-derived dendritic cells. International Immunology 14(4): 367-380
Ziegler-Heitbrock, Löms.; Lötzerich, M.; Schaefer, A.; Werner, T.; Frankenberger, M.; Benkhart, E. 2003: IFN-alpha induces the human IL-10 gene by recruiting both IFN regulatory factor 1 and Stat3. Journal of Immunology 171(1): 285-290
Chen, Y-Hsing.; Bieneman, A.P.; Creticos, P.S.; Chichester, K.L.; Schroeder, J.T. 2003: IFN-alpha inhibits IL-3 priming of human basophil cytokine secretion but not leukotriene C4 and histamine release. Journal of Allergy and Clinical Immunology 112(5): 944-950
Mathai, J.; Shimoda, K.; Banner, B.F.; Mori, M.; Bonkovsky, H.L.; Barnard, G.F. 1999: IFN-alpha receptor mRNA expression in a United States sample with predominantly genotype 1a/i chronic hepatitis C liver biopsies correlates with response to IFN therapy. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 19(9): 1011-1018
Pawelec, G.; Schlotz, E.; Rehbein, A. 1999: IFN-alpha regulates IL 10 production by CML cells in vitro. Cancer Immunology Immunotherapy: Cii 48(8): 430-434
Mohty, M.; Vialle-Castellano, A.; Nunes, J.A.; Isnardon, D.; Olive, D.; Gaugler, Béatrice. 2003: IFN-alpha skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities. Journal of Immunology 171(7): 3385-3393
Brass, U.; Tretter, T.; Schneller, F.; Schuler, M.; Huber, C.; Peschel, C. 1999: IFN-alpha stimulates proliferation and cytokine secretion of CD40-stimulated B cell chronic lymphocytic leukemia cells in vitro. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 19(4): 335-343
Travers, H.; Girdlestone, J. 1998: IFN-alpha super-induction of HLA class I expression by a variant thymoma cell line involves nuclear translocation of Rel complexes. European Journal of Immunology 28(11): 3792-3799
Braun, D.éb.; Caramalho, I.; Demengeot, J. 2002: IFN-alpha/beta enhances BCR-dependent B cell responses. International Immunology 14(4): 411-419
Brierley, M.M.; Fish, E.N. 2002: IFN-alpha/beta receptor interactions to biologic outcomes: Understanding the circuitry. Journal of Interferon and Cytokine Research 22(8): 835-845
Noisakran, S.; Campbell, I.L.; Carr, D.J. 2000: IFN-alpha1 plasmid construct affords protection against HSV-1 infection in transfected L929 fibroblasts. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 20(1): 107-115
Hussain, M.; Ni, D.; Gill, D.; Liao, M.J. 2000: IFN-alpha1a gene is the major variant in the North American population. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 20(9): 763-768
Padovan, E.; Spagnoli, G.C.; Ferrantini, M.; Heberer, M. 2002: IFN-alpha2a induces IP-10/CXCL10 and MIG/CXCL9 production in monocyte-derived dendritic cells and enhances their capacity to attract and stimulate CD8+ effector T cells. Journal of Leukocyte Biology 71(4): 669-676
Bauer, J.A.; Morrison, B.H.; Grane, R.W.; Jacobs, B.S.; Borden, E.C.; Lindner, D.J. 2003: IFN-alpha2b and thalidomide synergistically inhibit tumor-induced angiogenesis. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 23(1): 3-10
Tassopoulos, N.C.; Vafiadis, I.; Tsantoulas, D.; Syrokosta, J.; Hatzis, G.; Delladetsima, J.K.; Demonakou, M.; Sypsa, V.; Hatzakis, A.E. 2002: IFN-alpha2b monotherapy in patients with chronic hepatitis C and persistently normal or near normal aminotransferase activity: a randomized, controlled study. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 22(3): 365-369
Jablonowski, H. 2003: IFN-alpha: therapeutic options in HIV and HIV/HCV, HIV/HBV dual infection. Infection 31(2): 131-133
Van Weyenbergh, J.; P Silva, M.P.; Báfica, A.; Cardoso, S.; Wietzerbin, J.; Barral-Netto, M. 2001: IFN-beta and TGF-beta differentially regulate IL-12 activity in human peripheral blood mononuclear cells. Immunology Letters 75(2): 117-122
Créange, A.; Chazaud, B.; Plonquet, A.; Sharshar, T.; Poron, F.; Sonnet, C.; Raphaël, J.C.; Gherardi, R.K. 2001: IFN-beta decreases adhesion and transmigration capacities of lymphocytes in Guillain-Barré syndrome. Neurology 57(9): 1704-1706
Teige, I.; Treschow, A.; Teige, A.; Mattsson, R.; Navikas, V.; Leanderson, T.; Holmdahl, R.; Issazadeh-Navikas, S. 2003: IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis. Journal of Immunology 170(9): 4776-4784
Makar, T.Kumar.; Wilt, S.; Dong, Z.; Fishman, P.; Mouradian, M.Maral.; Dhib-Jalbut, S. 2002: IFN-beta gene transfer into the central nervous system using bone marrow cells as a delivery system. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 22(7): 783-791
Jungo, F.; Dayer, J.M.; Modoux, C.; Hyka, N.; Burger, D. 2001: IFN-beta inhibits the ability of T lymphocytes to induce TNF-alpha and IL-1beta production in monocytes upon direct cell-cell contact. Cytokine 14(5): 272-282
Bartholomé, E.J.; Willems, F.; Crusiaux, A.; Thielemans, K.; Schandene, L.; Goldman, M. 1999: IFN-beta interferes with the differentiation of dendritic cells from peripheral blood mononuclear cells: selective inhibition of CD40-dependent interleukin-12 secretion. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 19(5): 471-478
Jamaluddin, M.; Wang, S.; Garofalo, R.P.; Elliott, T.; Casola, A.; Baron, S.; Brasier, A.R. 2001: IFN-beta mediates coordinate expression of antigen-processing genes in RSV-infected pulmonary epithelial cells. American Journal of Physiology. Lung Cellular and Molecular Physiology 280(2): L248-L257
Chawla-Sarkar, M.; Leaman, D.W.; Jacobs, B.S.; Borden, E.C. 2002: IFN-beta pretreatment sensitizes human melanoma cells to TRAIL/Apo2 ligand-induced apoptosis. Journal of Immunology 169(2): 847-855
Zou, L.P.; Ma, D.H.; Wei, L.; van der Meide, P.H.; Mix, E.; Zhu, J. 1999: IFN-beta suppresses experimental autoimmune neuritis in Lewis rats by inhibiting the migration of inflammatory cells into peripheral nervous tissue. Journal of Neuroscience Research 56(2): 123-130
Waubant, E.; Gee, L.; Miller, K.; Stabler, G.; Goodkin, D. 2001: IFN-beta1a may increase serum levels of TIMP-1 in patients with relapsing-remitting multiple sclerosis. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 21(3): 181-185
Giorelli, M.; Livrea, P.; Defazio, G.; Ricchiuti, F.; Pagano, E.; Trojano, M. 2001: IFN-beta1a modulates the expression of CTLA-4 and CD28 splice variants in human mononuclear cells: induction of soluble isoforms. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 21(10): 809-812
Uitdehaag, B.M.; Hoekstra, K.; Koper, J.W.; Polman, C.H.; Dijkstra, C.D. 2001: IFN-beta1b augments glucocorticoid-induced suppression of tumor necrosis factor-alpha production by increasing the number of glucocorticoid receptors on a human monocytic cell line. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 21(3): 133-135
Chan, E.D.; Riches, D.W. 2001: IFN-gamma + LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38(mapk) in a mouse macrophage cell line. American Journal of Physiology. Cell Physiology 280(3): C441-C450
Dal Canto, A.J.; Swanson, P.E.; O'Guin, A.K.; Speck, S.H.; Virgin, H.W. 2001: IFN-gamma action in the media of the great elastic arteries, a novel immunoprivileged site. Journal of Clinical Investigation 107(2): R15-R22
Fromm, S.V.; Ehrlich, R. 2001: IFN-gamma affects both the stability and the intracellular transport of class I MHC complexes. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 21(4): 199-208
van Wissen, M.; Snoek, M.; Smids, B.; Jansen, H.M.; Lutter, Ré. 2002: IFN-gamma amplifies IL-6 and IL-8 responses by airway epithelial-like cells via indoleamine 2,3-dioxygenase. Journal of Immunology 169(12): 7039-7044
Wigginton, J.M.; Gruys, E.; Geiselhart, L.; Subleski, J.; Komschlies, K.L.; Park, J.W.; Wiltrout, T.A.; Nagashima, K.; Back, T.C.; Wiltrout, R.H. 2001: IFN-gamma and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy. Journal of Clinical Investigation 108(1): 51-62
Riemensberger, J.; Böhle, A.; Brandau, S. 2002: IFN-gamma and IL-12 but not IL-10 are required for local tumour surveillance in a syngeneic model of orthotopic bladder cancer. Clinical and Experimental Immunology 127(1): 20-26
Losana, G.; Bovolenta, C.; Rigamonti, L.; Borghi, I.; Altare, F.; Jouanguy, E.; Forni, G.; Casanova, J.-L.; Sherry, B.; Mengozzi, M.; Trinchieri, G.; Poli, G.; Gerosa, F.; Novelli, F. 2002: IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes. Journal of Leukocyte Biology 72(4): 735-742
Kumar, M.; Behera, A.K.; Hu, J.; Lockey, R.F.; Mohapatra, S.S. 2001: IFN-gamma and IL-12 plasmid DNAs as vaccine adjuvant in a murine model of grass allergy. Journal of Allergy and Clinical Immunology 108(3): 402-408
Coccia, E.M.; Stellacci, E.; Marziali, G.; Weiss, G.; Battistini, A. 2000: IFN-gamma and IL-4 differently regulate inducible NO synthase gene expression through IRF-1 modulation. International Immunology 12(7): 977-985
Banu, N.; Meyers, C.M. 1999: IFN-gamma and LPS differentially modulate class Ii MHC and B7-1 expression on murine renal tubular epithelial cells. Kidney International 55(6): 2250-2263
Broderick, C.; Duncan, L.; Taylor, N.; Dick, A.D. 2000: IFN-gamma and LPS-mediated IL-10-dependent suppression of retinal microglial activation. IOVS Investigative Ophthalmology and Visual Science 41(9): 2613-2622
Cooper, A.M.; Adams, L.B.; Dalton, D.K.; Appelberg, R.; Ehlers, S. 2002: IFN-gamma and NO in mycobacterial disease: new jobs for old hands. Trends in Microbiology 10(5): 221-226
Murata, Y.; Ohteki, T.; Koyasu, S.; Hamuro, J. 2002: IFN-gamma and pro-inflammatory cytokine production by antigen-presenting cells is dictated by intracellular thiol redox status regulated by oxygen tension. European Journal of Immunology 32(10): 2866-2873
Cormican, L.; O'Sullivan, S.; Burke, C.M.; Poulter, L.W. 2001: IFN-gamma but not IL-4 T cells of the asthmatic bronchial wall show increased incidence of apoptosis. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 31(5): 731-739
Yi, S.; O'Connell, P.J. 2002: IFN-gamma but not IL-4 is important for mouse CD4+ T cell-mediated macrophage activation following their exposure to pig cells in vitro. Xenotransplantation 9(4): 268-276
Whitman, S.C.; Ravisankar, P.; Daugherty, A. 2002: IFN-gamma deficiency exerts gender-specific effects on atherogenesis in apolipoprotein E-/- mice. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 22(6): 661-670
Walravens, K.; Marché, S.; Rosseels, V.; Wellemans, V.; Boelaert, F.; Huygen, K.; Godfroid, J. 2002: IFN-gamma diagnostic tests in the context of bovine mycobacterial infections in Belgium. Veterinary Immunology and Immunopathology 87(3-4): 401-406
Rocha, F.; Musch, M.W.; Lishanskiy, L.; Bookstein, C.; Sugi, K.; Xie, Y.; Chang, E.B. 2001: IFN-gamma downregulates expression of Na(+)/H(+) exchangers NHE2 and NHE3 in rat intestine and human Caco-2/bbe cells. American Journal of Physiology. Cell Physiology 280(5): C1224-C1232
Bonder, C.S.; Davies, K.V.L.; Hosszu, E.K.; Finlay-Jones, J.J.; Hart, P.H. 2002: IFN-gamma downregulates interleukin-4 functional activity on monocytes by multiple mechanisms. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 22(3): 287-293
Madyastha, P.R.; Yang, S.; Ries, W.L.; Key, L.L. 2000: IFN-gamma enhances osteoclast generation in cultures of peripheral blood from osteopetrotic patients and normalizes superoxide production. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 20(7): 645-652
Athanassakis, I.; Ranella, A.; Vassiliadis, S. 2000: IFN-gamma facilitates release of class II-loaded intracellular pools in trophoblast cells: a novel property independent of protein synthesis. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 20(9): 823-830
Hasegawa, T.; Nakao, A.; Sumiyoshi, K.; Tsuboi, R.; Ogawa, H. 2003: IFN-gamma fails to antagonize fibrotic effect of TGF-beta on keloid-derived dermal fibroblasts. Journal of Dermatological Science 32(1): 19-24
Zhang, L.; Mi, J.; Yu, Y.; Yao, H.; Chen, H.; Li, M.; Cao, X. 2001: IFN-gamma gene therapy by intrasplenic hepatocyte transplantation: a novel strategy for reversing hepatic fibrosis in Schistosoma japonicum-infected mice. Parasite Immunology 23(1): 11-17
Gong, F-Ying.; Deng, J-Ying.; Shi, Y-Fan. 2003: IFN-gamma increases the hGH gene promoter activity in rat GH3 cells. Hormone Research 60(1): 14-20
Zou, G.M.; Reznikoff-Etievant, M.F.; Hirsch, F.; Milliez, J. 2000: IFN-gamma induces apoptosis in mouse embryonic stem cells, a putative mechanism of its embryotoxicity. Development Growth and Differentiation 42(3): 257-264
Shin, E.C.; Ahn, J.M.; Kim, C.H.; Choi, Y.; Ahn, Y.S.; Kim, H.; Kim, S.J.; Park, J.H. 2001: IFN-gamma induces cell death in human hepatoma cells through a TRAIL/death receptor-mediated apoptotic pathway. International Journal of Cancer 93(2): 262-268
Rendon-Mitchell, B.; Ochani, M.; Li, J.; Han, J.; Wang, H.; Yang, H.; Susarla, S.; Czura, C.; Mitchell, R.A.; Chen, G.; Sama, A.E.; Tracey, K.J.; Wang, H. 2003: IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism. Journal of Immunology 170(7): 3890-3897
Kim, S-Youl.; Jeong, E-Joo.; Steinert, P.M. 2002: IFN-gamma induces transglutaminase 2 expression in rat small intestinal cells. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 22(6): 677-682
Hobeika, A.C.; Etienne, W.; Torres, B.A.; Johnson, H.M.; Subramaniam, P.S. 1999: IFN-gamma induction of p21(WAF1) is required for cell cycle inhibition and suppression of apoptosis. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 19(12): 1351-1361
Park, S-Youel.; Billiar, T.R.; Seol, D-Wu. 2002: IFN-gamma inhibition of TRAIL-induced IAP-2 upregulation, a possible mechanism of IFN-gamma-enhanced TRAIL-induced apoptosis. Biochemical and Biophysical Research Communications 291(2): 233-236
Amrani, Y.; Tliba, O.; Choubey, D.; Huang, C.-D.; Krymskaya, V.P.; Eszterhas, A.; Lazaar, A.L.; Panettieri, R.A. 2003: IFN-gamma inhibits human airway smooth muscle cell proliferation by modulating the E2F-1/Rb pathway. American Journal of Physiology. Lung Cellular and Molecular Physiology 284(6): L1063-L1071
Kim, J.G.; Hahn, Y.S. 2000: IFN-gamma inhibits the suppressive effects of PGE2 on the production of tumor necrosis factor-alpha by mouse macrophages. Immunological Investigations 29(3): 257-269
Jackson, S.H.; Miller, G.F.; Segal, B.H.; Mardiney, M.; Domachowske, J.B.; Gallin, J.I.; Holland, S.M. 2001: IFN-gamma is effective in reducing infections in the mouse model of chronic granulomatous disease (CGD). Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 21(8): 567-573
Jung, T.; Witzak, K.; Dieckhoff, K.; Zachmann, K.; Heidrich, S.; Aversa, G.; Neumann, C. 1999: IFN-gamma is only partially restored by co-stimulation with IL-12, IL-2, IL-15, IL-18 or engagement of CD28. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 29(2): 207-216
Wang, S.; Fan, Y.; Brunham, R.C.; Yang, X. 1999: IFN-gamma knockout mice show Th2-associated delayed-type hypersensitivity and the inflammatory cells fail to localize and control chlamydial infection. European Journal of Immunology 29(11): 3782-3792
Kitching, A.R.; Holdsworth, S.R.; Tipping, P.G. 1999: IFN-gamma mediates crescent formation and cell-mediated immune injury in murine glomerulonephritis. Journal of the American Society of Nephrology: Jasn 10(4): 752-759
Krakowski, M.; Yeung, B.; Abdelmalik, R.; Good, A.; Mocnik, L.; Sosa-Pineda, B.; St-Onge, L.; Gruss, P.; Sarvetnick, N. 2000: IFN-gamma overexpression within the pancreas is not sufficient to rescue Pax4, Pax6, and Pdx-1 mutant mice from death. Pancreas 21(4): 399-406
Kimura, M.; Tsuruta, S.; Yoshida, T. 2000: IFN-gamma plays a dominant role in upregulation of Candida-specific IgE synthesis in patients with atopic dermatitis. International Archives of Allergy and Immunology 122(3): 195-199
Déry, R.E.; Bissonnette, E.Y. 1999: IFN-gamma potentiates the release of TNF-alpha and MIP-1alpha by alveolar macrophages during allergic reactions. American Journal of Respiratory Cell and Molecular Biology 20(3): 407-412
Anderson, F.; Game, B.A.; Atchley, D.; Xu, M.; Lopes-Virella, M.F.; Huang, Y. 2002: IFN-gamma pretreatment augments immune complex-induced matrix metalloproteinase-1 expression in U937 histiocytes. Clinical Immunology 102(2): 200-207
Frucht, D.M.; Fukao, T.; Bogdan, C.; Schindler, H.; O'Shea, J.J.; Koyasu, S. 2001: IFN-gamma production by antigen-presenting cells: mechanisms emerge. Trends in Immunology 22(10): 556-560
Timoshanko, J.R.; Holdsworth, S.R.; Kitching, A.R.; Tipping, P.G. 2002: IFN-gamma production by intrinsic renal cells and bone marrow-derived cells is required for full expression of crescentic glomerulonephritis in mice. Journal of Immunology 168(8): 4135-4141
Ami, K.; Kinoshita, M.; Yamauchi, A.; Nishikage, T.; Habu, Y.; Shinomiya, N.; Iwai, T.; Hiraide, H.; Seki, S. 2002: IFN-gamma production from liver mononuclear cells of mice in burn injury as well as in postburn bacterial infection models and the therapeutic effect of IL-18. Journal of Immunology 169(8): 4437-4442
Spaggiari, G.Maria.; Contini, P.; Negrini, S.; Dondero, A.; Carosio, R.; Ghio, M.; Puppo, F.; Indiveri, F.; Zocchi, M.Raffaella.; Poggi, A. 2003: IFN-gamma production in human NK cells through the engagement of CD8 by soluble or surface HLA class I molecules. European Journal of Immunology 33(11): 3049-3059
Muscettola, M.; Massai, L.; Lodi, L.; Briganti, F.; Fontani, G.; Lupo, C. 2003: IFN-gamma production in rabbits: behavioral and endocrine correlates. Life Sciences 72(12): 1331-1343
Shikano, H.; Kato, Z.; Kaneko, H.; Watanabe, M.; Inoue, R.; Kasahara, K.; Takemura, M.; Kondo, N. 2001: IFN-gamma production in response to IL-18 or IL-12 stimulation by peripheral blood mononuclear cells of atopic patients. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 31(8): 1263-1270
Yin, D.; Dujovny, N.; Ma, L.; Varghese, A.; Shen, J.; Bishop, D.Keith.; Chong, A.S. 2003: IFN-gamma production is specifically regulated by IL-10 in mice made tolerant with anti-CD40 ligand antibody and intact active bone. Journal of Immunology 170(2): 853-860
Malmberg, K.-J.; Levitsky, V.; Norell, H.åk.; de Matos, C.T.; Carlsten, M.; Schedvins, K.; Rabbani, H.; Moretta, A.; Söderström, K.; Levitskaya, J.; Kiessling, R. 2002: IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism. Journal of Clinical Investigation 110(10): 1515-1523
Elser, B.; Lohoff, M.; Kock, S.; Giaisi, M.; Kirchhoff, S.; Krammer, P.H.; Li-Weber, M. 2002: IFN-gamma represses IL-4 expression via IRF-1 and IRF-2. Immunity 17(6): 703-712
Tay, S.S.; McCormack, A.; Lawson, C.; Rose, M.L. 2003: IFN-gamma reverses the stop signal allowing migration of antigen-specific T cells into inflammatory sites. Journal of Immunology 170(6): 3315-3322
Suzuki, M.; Maghni, K.; Molet, S.; Shimbara, A.; Hamid, Q.A.; Martin, J.G. 2002: IFN-gamma secretion by CD8T cells inhibits allergen-induced airway eosinophilia but not late airway responses. Journal of Allergy and Clinical Immunology 109(5): 803-809
Lukacher, A.E. 2002: IFN-gamma suspends the killing license of anti-tumor CTLs. Journal of Clinical Investigation 110(10): 1407-1409
Kraft, M.; Riedel, S.; Maaser, C.; Kucharzik, T.; Steinbuechel, A.; Domschke, W.; Luegering, N. 2001: IFN-gamma synergizes with TNF-alpha but not with viable H. pylori in up-regulating CXC chemokine secretion in gastric epithelial cells. Clinical and Experimental Immunology 126(3): 474-481
Wu, Y.; Lin, Y.; Hou, W.; Wang, Y.; Sun, B. 2003: IFN-gamma up-regulation of IL-12 beta 2 receptor is associated with experimental autoimmune uveitis susceptible B10.A mice, but not in EAU resistant BALB/c mice. Journal of Neuroimmunology 137(1-2): 154-163
Araujo, Z.; Heremans, H.; Stordeur, P.; Wissing, M.; Goldman, M.; Castes, M.; Carlier, Y. 2000: IFN-gamma, IL-4, IL-10 and IL-12 gene expression in BCG-Leishmania vaccination of Trypanosoma cruzi-infected mice. Vaccine 18(17): 1822-1829
Shi, Z.O-Quan.; Fischer, M.J.; De Sanctis, G.T.; Schuyler, M.R.; Tesfaigzi, Y. 2002: IFN-gamma, but not Fas, mediates reduction of allergen-induced mucous cell metaplasia by inducing apoptosis. Journal of Immunology 168(9): 4764-4771
Hertz, C.J.; Mansfield, J.M. 1999: IFN-gamma-dependent nitric oxide production is not linked to resistance in experimental African trypanosomiasis. Cellular Immunology 192(1): 24-32
Herrero, C.; Marqués, L.; Lloberas, J.; Celada, A. 2001: IFN-gamma-dependent transcription of MHC class II IA is impaired in macrophages from aged mice. Journal of Clinical Investigation 107(4): 485-493
Thiam, K.; Loing, E.; Verwaerde, C.; Auriault, C.; Gras-Masse, H. 1999: IFN-gamma-derived lipopeptides: influence of lipid modification on the conformation and the ability to induce MHC class II expression on murine and human cells. Journal of Medicinal Chemistry 42(18): 3732-3736
Markine-Goriaynoff, D.; van der Logt, J.T.; Truyens, C.; Nguyen, T.D.; Heessen, F.W.; Bigaignon, G.; Carlier, Y.; Coutelier, J.P. 2000: IFN-gamma-independent IgG2a production in mice infected with viruses and parasites. International Immunology 12(2): 223-230
Helmby, H.; Grencis, R.K. 2003: IFN-gamma-independent effects of IL-12 during intestinal nematode infection. Journal of Immunology 171(7): 3691-3696
Comes, A.; Di Carlo, E.; Musiani, P.; Rosso, O.; Meazza, R.; Chiodoni, C.; Colombo, M.P.; Ferrini, S. 2002: IFN-gamma-independent synergistic effects of IL-12 and IL-15 induce anti-tumor immune responses in syngeneic mice. European Journal of Immunology 32(7): 1914-1923
Dellacasagrande, J.ér.ôm.; Ghigo, E.; Raoult, D.; Capo, C.; Mege, J.-L. 2002: IFN-gamma-induced apoptosis and microbicidal activity in monocytes harboring the intracellular bacterium Coxiella burnetii require membrane TNF and homotypic cell adherence. Journal of Immunology 169(11): 6309-6315
Everding, B.; Wilhelm, S.; Averesch, S.; Scherdin, U.; Hölzel, F.; Steffen, M. 2000: IFN-gamma-induced change in microtubule organization and alpha-tubulin expression during growth inhibition of lung squamous carcinoma cells. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 20(11): 983-990
Mohan, K.; Ding, Z.; Hanly, J.; Issekutz, T.B. 2002: IFN-gamma-inducible T cell alpha chemoattractant is a potent stimulator of normal human blood T lymphocyte transendothelial migration: differential regulation by IFN-gamma and TNF-alpha. Journal of Immunology 168(12): 6420-6428
Horikawa, T.; Nakayama, T.; Hikita, I.; Yamada, H.; Fujisawa, R.; Bito, T.; Harada, S.; Fukunaga, A.; Chantry, D.; Gray, P.W.; Morita, A.; Suzuki, R.; Tezuka, T.; Ichihashi, M.; Yoshie, O. 2002: IFN-gamma-inducible expression of thymus and activation-regulated chemokine/CCL17 and macrophage-derived chemokine/CCL22 in epidermal keratinocytes and their roles in atopic dermatitis. International Immunology 14(7): 767-773
Medoff, B.D.; Sauty, A.; Tager, A.M.; Maclean, J.A.; Smith, R.Neal.; Mathew, A.; Dufour, J.H.; Luster, A.D. 2002: IFN-gamma-inducible protein 10 (CXCL10) contributes to airway hyperreactivity and airway inflammation in a mouse model of asthma. Journal of Immunology 168(10): 5278-5286
Dufour, J.H.; Dziejman, M.; Liu, M.T.; Leung, J.H.; Lane, T.E.; Luster, A.D. 2002: IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. Journal of Immunology 168(7): 3195-3204
Frissora, F.; Chen, H.-C.; Durbin, J.; Bondada, S.; Muthusamy, N. 2003: IFN-gamma-mediated inhibition of antigen receptor-induced B cell proliferation and CREB-1 binding activity requires STAT-1 transcription factor. European Journal of Immunology 33(4): 907-912
Hayakawa, Y.; Takeda, K.; Yagita, H.; Smyth, M.J.; Van Kaer, L.; Okumura, K.; Saiki, I. 2002: IFN-gamma-mediated inhibition of tumor angiogenesis by natural killer T-cell ligand, alpha-galactosylceramide. Blood 100(5): 1728-1733
Teraki, Y.; Shiohara, T. 2003: IFN-gamma-producing effector CD8+ T cells and IL-10-producing regulatory CD4+ T cells in fixed drug eruption. Journal of Allergy and Clinical Immunology 112(3): 609-615
Norose, K.; Mun, H-Seong.; Aosai, F.; Chen, M.; Piao, L-Xun.; Kobayashi, M.; Iwakura, Y.; Yano, A. 2003: IFN-gamma-regulated Toxoplasma gondii distribution and load in the murine eye. IOVS Investigative Ophthalmology and Visual Science 44(10): 4375-4381
Kotenko, S.V.; Gallagher, G.; Baurin, V.V.; Lewis Antes, A.; Shen, M.; Shah, N.K.; Langer, J.A.; Sheikh, F.; Dickensheets, H.; Donnelly, R.P. 2003: IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nature Immunology 4(1): 69-77
Meraro, D.; Gleit-Kielmanowicz, M.; Hauser, Hörg.; Levi, B-Zion. 2002: IFN-stimulated gene 15 is synergistically activated through interactions between the myelocyte/lymphocyte-specific transcription factors, PU.1, IFN regulatory factor-8/IFN consensus sequence binding protein, and IFN regulatory factor-4: characterization of a new subtype of IFN-stimulated response element. Journal of Immunology 168(12): 6224-6231
Johnson, J.A.; Hochkeppel, H.K.; Gangemi, J.D. 1999: IFN-tau exhibits potent suppression of human papillomavirus E6/E7 oncoprotein expression. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 19(10): 1107-1116
Mujtaba, M.G.; Villarete, L.; Johnson, H.M. 1999: IFN-tau inhibits IgE production in a murine model of allergy and in an IgE-producing human myeloma cell line. Journal of Allergy and Clinical Immunology 104(5): 1037-1044
Martal, J.L.; Chêne, N.M.; Huynh, L.P.; L'Haridon, R.M.; Reinaud, P.B.; Guillomot, M.W.; Charlier, M.A.; Charpigny, S.Y. 1998: IFN-tau: A novel subtype I IFN1. Structural characteristics, non-ubiquitous expression, structure-function relationships, a pregnancy hormonal embryonic signal and cross-species therapeutic potentialities. Biochimie 80(8-9): 755-777
Moro, A.; Perea, S.E.; Pantoja, C.; Santos, A.; Araña, M.D.; Serrano, M. 2001: IFNalpha 2b induces apoptosis and proteasome-mediated degradation of p27Kip1 in a human lung cancer cell line. Oncology Reports 8(2): 425-429
Liang, S.; Wei, H.; Sun, R.; Tian, Z. 2003: IFNalpha regulates NK cell cytotoxicity through STAT1 pathway. Cytokine 23(6): 190-199
Suk, K.; Kim, Y.H.; Chang, I.; Kim, J.Y.; Choi, Y.H.; Lee, K.Y.; Lee, M.S. 2001: IFNalpha sensitizes ME-180 human cervical cancer cells to TNFalpha-induced apoptosis by inhibiting cytoprotective NF-kappaB activation. Febs Letters 495(1-2): 66-70
Lehmann, T.; Lämmle, B. 1999: IFNalpha treatment in systemic mastocytosis. Annals of Hematology 78(10): 483-484
Waubant, E.; Goodkin, D.; Bostrom, A.; Bacchetti, P.; Hietpas, J.; Lindberg, R.; Leppert, D. 2003: IFNbeta lowers MMP-9/TIMP-1 ratio, which predicts new enhancing lesions in patients with SPMS. Neurology 60(1): 52-57
Sopp, P.; Howard, C.J. 2001: IFN gamma and IL-4 production by CD4, CD8 and WC1 gamma delta TCR(+) T cells from cattle lymph nodes and blood. Veterinary immunology and immunopathology 81(1-2): 85-96
Calorini, L.; Bianchini, F.; Mannini, A.; Mugnai, G.; Balzi, M.; Becciolini, A.; Ruggieri, S. 2002: IFNgamma and TNFalpha account for a pro-clonogenic activity secreted by activated murine peritoneal macrophages. Clinical and Experimental Metastasis 19(3): 259-264
Jensen, M.B.; Hegelund, I.V.; Lomholt, N.D.; Finsen, B.; Owens, T. 2000: IFNgamma enhances microglial reactions to hippocampal axonal degeneration. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 20(10): 3612-3621
Schwarz, M.; Wahl, M.; Resch, K.; Radeke, H.H. 2002: IFNgamma induces functional chemokine receptor expression in human mesangial cells. Clinical and Experimental Immunology 128(2): 285-294
Kominsky, S.; Johnson, H.M.; Bryan, G.; Tanabe, T.; Hobeika, A.C.; Subramaniam, P.S.; Torres, B. 1998: IFNgamma inhibition of cell growth in glioblastomas correlates with increased levels of the cyclin dependent kinase inhibitor p21WAF1/CIP1. Oncogene 17(23): 2973-2979
Zier, K.; Johnson, K.; Maddux, J.M.; Sung, M.; Mandeli, J.; Eisenbach, L.; Schwartz, M. 2000: IFNgamma secretion following stimulation with total tumor peptides from autologous human tumors. Journal of Immunological Methods 241(1-2): 61-68
Decker, T.; Stockinger, S.; Karaghiosoff, M.; Müller, M.; Kovarik, P. 2002: IFNs and STATs in innate immunity to microorganisms. Journal of Clinical Investigation 109(10): 1271-1277
Katakura, Y.; Yuki, T.; Satou, T.; Ishida, K.; Itou, K.; Kobayashi, G.; Kimura, K.; Matsunaga, A.; Nomura, M.; Kikuchi, T.; Uchimi, K.; Seno, S.; Okubo, K.; Suzuki, T.; Hirasawa, D.; Noda, Y.; Fujita, N. 2000: IFOBT-positive gastric cancer. Nihon Shokakibyo Gakkai Zasshi Japanese Journal of Gastro-Enterology 97(6): 691-696
Baker, S.A.; Freeman, K.; Luby-Phelps, K.; Pazour, G.J.; Besharse, J.C. 2003: IFT20 links kinesin Ii with a mammalian intraflagellar transport complex that is conserved in motile flagella and sensory cilia. Journal of Biological Chemistry 278(36): 34211-34218
Bräuer, A.U.; Savaskan, N.E.; Plaschke, M.; Prehn, S.; Ninnemann, O.; Nitsch, R. 2000: IG-molecule Kilon shows differential expression pattern from LAMP in the developing and adult rat hippocampus. Hippocampus 10(6): 632-644
Smink, J.J.; Koster, J.G.; Gresnigt, M.G.; Rooman, R.; Koedam, J.A.; Van Buul-Offers, S.C. 2002: IGF and IGF-binding protein expression in the growth plate of normal, dexamethasone-treated and human IGF-II transgenic mice. Journal of Endocrinology 175(1): 143-153
Fang, J.; Furesz, T.C.; Smith, C.H.; Fant, M.E. 1999: IGF binding protein-1 (IGFBP-1) is preferentially associated with the fetal-facing basal surface of the syncytiotrophoblast in the human placenta. Growth Hormone and Igf Research: Official Journal of the Growth Hormone Research Society and the International Igf Research Society 9(6): 438-444
Campbell, M.J.; Woodside, J.V.; Secker-Walker, J.; Titcomb, A.; Leathem, A.J. 2001: IGF status is altered by tamoxifen in patients with breast cancer. Molecular Pathology: Mp 54(5): 307-310
Ducos, B.; Cabrol, S.; Houang, M.; Perin, L.; Holzenberger, M.; Le Bouc, Y. 2001: IGF type 1 receptor ligand binding characteristics are altered in a subgroup of children with intrauterine growth retardation. Journal of Clinical Endocrinology and Metabolism 86(11): 5516-5524
Franciosi, C.M.; Piacentini, M.G.; Conti, M.; Romano, F.; Musco, F.; Caprotti, R.; Rovelli, F.; Uggeri, F. 2003: IGF-1 and IGF-1BP3 in gastric adenocarcinoma. Preliminary study. Hepato-Gastroenterology 50(49): 297-300
Parkhouse, W.S.; Coupland, D.C.; Li, C.; Vanderhoek, K.J. 2000: IGF-1 bioavailability is increased by resistance training in older women with low bone mineral density. Mechanisms of Ageing and Development 113(2): 75-83
Lupia, E.; Elliot, S.J.; Lenz, O.; Zheng, F.; Hattori, M.; Striker, G.E.; Striker, L.J. 1999: IGF-1 decreases collagen degradation in diabetic NOD mesangial cells: implications for diabetic nephropathy. Diabetes 48(8): 1638-1644
Flint, P.W.; Shiotani, A.; O'Malley, B.W. 1999: IGF-1 gene transfer into denervated rat laryngeal muscle. Archives of Otolaryngology--Head and Neck Surgery 125(3): 274-279
Druckmann, R.; Rohr, U.D. 2002: IGF-1 in gynaecology and obstetrics: Update 2002. Maturitas 41(Suppl): S65-S83
Berfield, A.K.; Abrass, C.K. 2002: IGF-1 induces foam cell formation in rat glomerular mesangial cells. Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society 50(3): 395-403
Deleu, S.; Pirson, I.; Coulonval, K.; Drouin, A.; Taton, M.; Clermont, F.; Roger, P.P.; Nakamura, T.; Dumont, J.E.; Maenhaut, C. 1999: IGF-1 or insulin, and the TSH cyclic AMP cascade separately control dog and human thyroid cell growth and DNA synthesis, and complement each other in inducing mitogenesis. Molecular and Cellular Endocrinology 149(1-2): 41-51
Kajstura, J.; Fiordaliso, F.; Andreoli, A.M.; Li, B.; Chimenti, S.; Medow, M.S.; Limana, F.; Nadal-Ginard, B.; Leri, A.; Anversa, P. 2001: IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes 50(6): 1414-1424
Samarel, A.M. 2002: IGF-1 Overexpression rescues the failing heart. Circulation Research 90(6): 631-633
Kim, J.-H.; Park, H.-H.; Lee, C.-E. 2003: IGF-1 potentiation of IL-4-induced CD23/Fc(epsilon)RIi expression in human B cells. Molecules and Cells 15(3): 307-312
Baudry, A.; Lamothe, B.; Bucchini, D.; Jami, J.; Montarras, D.; Pinset, C.; Joshi, R.L. 2001: IGF-1 receptor as an alternative receptor for metabolic signaling in insulin receptor-deficient muscle cells. FEBS Letters 488(3): 174-178
Morales, M.P.; Gálvez, A.; Eltit, J.M.; Ocaranza, P.; Díaz-Araya, G.; Lavandero, S. 2000: IGF-1 regulates apoptosis of cardiac myocyte induced by osmotic-stress. Biochemical and Biophysical Research Communications 270(3): 1029-1035
Mockridge, J.W.; Benton, E.C.; Andreeva, L.V.; Latchman, D.S.; Marber, M.S.; Heads, R.J. 2000: IGF-1 regulates cardiac fibroblast apoptosis induced by osmotic stress. Biochemical and Biophysical Research Communications 273(1): 322-327
Hashimoto, N.; Ohyanagi, H. 2001: IGF-1 stimulates mucosal growth in ileal Thiry-Vella fistulas. Hepato-Gastroenterology 48(38): 413-415
Gamper, N.; Fillon, S.; Huber, S.M.; Feng, Y.; Kobayashi, T.; Cohen, P.; Lang, F. 2002: IGF-1 up-regulates K+ channels via PI3-kinase, PDK1 and SGK1. Pflugers Archiv: European Journal of Physiology 443(4): 625-634
Probst-Hensch, N.M.; Yuan, J.M.; Stanczyk, F.Z.; Gao, Y.T.; Ross, R.K.; Yu, M.C. 2001: IGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: association with colorectal cancer in a cohort of Chinese men in Shanghai. British Journal of Cancer 85(11): 1695-1699
Berfield, A.K.; Andress, D.L.; Abrass, C.K. 2002: IGF-1-induced lipid accumulation impairs mesangial cell migration and contractile function. Kidney International 62(4): 1229-1237
Peters, G.; Gongoll, S.; Langner, C.; Mengel, M.; Piso, P.; Klempnauer, J.ür.; Rüschoff, J.; Kreipe, H.; von Wasielewski, R. 2003: IGF-1R, IGF-1 and IGF-2 expression as potential prognostic and predictive markers in colorectal-cancer. Virchows Archiv: An International Journal of Pathology 443(2): 139-145
Brisken, C.; Ayyannan, A.; Nguyen, C.; Heineman, A.; Reinhardt, F.; Tan, J.; Dey, S.K.; Dotto, G.Paolo.; Weinberg, R.A.; Jan, T. 2002: IGF-2 is a mediator of prolactin-induced morphogenesis in the breast. Developmental Cell 3(6): 877-887
Rhodes, C.J. 2000: IGF-I and GH post-receptor signaling mechanisms for pancreatic beta-cell replication. Journal of Molecular Endocrinology 24(3): 303-311
Ibañez De Cáceres, I.; Villanúa, M.A.; Soto, L.; Martin, A.I.; López-Calderón, A. 2000: IGF-i and IGF-I-binding proteins in rats with adjuvant-induced arthritis given recombinant human growth hormone. Journal of Endocrinology 165(3): 537-544
Das, U.; Whatmore, A.J.; Khosravi, J.; Wales, J.K.H.; Butler, G.; Kibirige, M.S.; Diamandi, A.; Jones, J.; Patel, L.; Hall, C.M.; Price, D.A.; Clayton, P.E. 2003: IGF-I and IGF-binding protein-3 measurements on filter paper blood spots in children and adolescents on GH treatment: use in monitoring and as markers of growth performance. European Journal of Endocrinology 149(3): 179-185
Schmidmaier, G.; Wildemann, B.; Lübberstedt, M.; Haas, N.P.; Raschke, M. 2003: IGF-I and TGF-beta 1 incorporated in a poly(D,L-lactide) implant coating stimulates osteoblast differentiation and collagen-1 production but reduces osteoblast proliferation in cell culture. Journal of Biomedical Materials Research. Part B Applied Biomaterials 65(1): 157-162
Kandziora, F.; Schmidmaier, G.; Schollmeier, G.; Bail, H.; Pflugmacher, R.; Görke, T.; Wagner, M.; Raschke, M.; Mittlmeier, T.; Haas, N.P. 2002: IGF-I and TGF-beta1 application by a poly-(D,L-lactide)-coated cage promotes intervertebral bone matrix formation in the sheep cervical spine. Spine 27(16): 1710-1723
Simmons, J.G.; Pucilowska, J.B.; Keku, T.O.; Lund, P.Kay. 2002: IGF-I and TGF-beta1 have distinct effects on phenotype and proliferation of intestinal fibroblasts. American Journal of Physiology. Gastrointestinal and Liver Physiology 283(3): G809-G818
Clarkson, E.D.; Zawada, W.M.; Bell, K.P.; Esplen, J.E.; Choi, P.K.; Heidenreich, K.A.; Freed, C.R. 2001: IGF-i and bFGF improve dopamine neuron survival and behavioral outcome in parkinsonian rats receiving cultured human fetal tissue strands. Experimental Neurology 168(1): 183-191
Gooch, K.J.; Blunk, T.; Courter, D.L.; Sieminski, A.L.; Bursac, P.M.; Vunjak-Novakovic, G.; Freed, L.E. 2001: IGF-i and mechanical environment interact to modulate engineered cartilage development. Biochemical and Biophysical Research Communications 286(5): 909-915
Pucilowska, J.B.; McNaughton, K.K.; Mohapatra, N.K.; Hoyt, E.C.; Zimmermann, E.M.; Sartor, R.B.; Lund, P.K. 2000: IGF-I and procollagen alpha1(I) are coexpressed in a subset of mesenchymal cells in active Crohn's disease. American Journal of Physiology. Gastrointestinal and Liver Physiology 279(6): G1307-G1322
Oosterlaken-Dijksterhuis, M.A.; Kwant, M.M.; Slob, A.; Hellmén, E.; Mol, J.A. 1999: IGF-I and retinoic acid regulate the distribution pattern of IGFBPs synthesized by the canine mammary tumor cell line CMT-U335. Breast Cancer Research and Treatment 54(1): 11-23
Jehle, A.W.; Forgo, J.; Biber, J.; Lederer, E.; Krapf, R.; Murer, H. 1998: IGF-I and vanadate stimulate Na/Pi-cotransport in OK cells by increasing type II Na/Pi-cotransporter protein stability. Pflugers Archiv: European Journal of Physiology 437(1): 149-154
Castillo, J.; Le Bail, P.-Y.; Paboeuf, G.; Navarro, I.; Weil, C.; Fauconneau, B.; Gutiérrez, J. 2002: IGF-i binding in primary culture of muscle cells of rainbow trout: changes during in vitro development. American Journal of Physiology. Regulatory Integrative and Comparative Physiology 283(3): R647-R652
Voss, T.C.; Flynn, M.P.; Hurley, D.L. 2001: IGF-i causes an ultrasensitive reduction in GH mRNA levels via an extracellular mechanism involving IGF binding proteins. Molecular Endocrinology 15(9): 1549-1558
Gao, W.Q.; Shinsky, N.; Ingle, G.; Beck, K.; Elias, K.A.; Powell-Braxton, L. 1999: IGF-I deficient mice show reduced peripheral nerve conduction velocities and decreased axonal diameters and respond to exogenous IGF-I treatment. Journal of Neurobiology 39(1): 142-152
Yamamura, T.; Otani, H.; Nakao, Y.; Hattori, R.; Osako, M.; Imamura, H. 2001: IGF-i differentially regulates Bcl-xL and Bax and confers myocardial protection in the rat heart. American Journal of Physiology. Heart and Circulatory Physiology 280(3): H1191-H1200
Walsh, S.; Jefferiss, C.M.; Stewart, K.; Beresford, J.N. 2003: IGF-I does not affect the proliferation or early osteogenic differentiation of human marrow stromal cells. Bone 33(1): 80-89
de Pablo, F.; Banner, L.R.; Patterson, P.H. 2000: IGF-I expression is decreased in LIF-deficient mice after peripheral nerve injury. Neuroreport 11(6): 1365-1368
Aberg, M.A.I.; Aberg, N.David.; Palmer, T.D.; Alborn, A-Marie.; Carlsson-Skwirut, C.; Bang, P.; Rosengren, L.E.; Olsson, T.; Gage, F.H.; Eriksson, P.S. 2003: IGF-I has a direct proliferative effect in adult hippocampal progenitor cells. Molecular and Cellular Neurosciences 24(1): 23-40
Gersl, V.; Cerman, J.; Suba, P.; Mazurová, Y.; Hrdina, R.; Machácková, J. 1999: IGF-i in experimental daunorubicin-induced cardiomyopathy in rabbits. Human and Experimental Toxicology 18(3): 154-161
Eppler, E.; Zapf, J.; Bailer, N.; Falkmer, U.G.; Falkmer, S.; Reinecke, M. 2002: IGF-I in human breast cancer: low differentiation stage is associated with decreased IGF-I content. European Journal of Endocrinology 146(6): 813-821
Tu, W.; Cheung, P.T.; Lau, Y.L. 1999: IGF-I increases interferon-gamma and IL-6 mRNA expression and protein production in neonatal mononuclear cells. Pediatric Research 46(6): 748-754
Lang, C.H.; Kumar, V.; Liu, X.; Frost, R.A.; Vary, T.C. 2003: IGF-i induced phosphorylation of S6K1 and 4E-BP1 in heart is impaired by acute alcohol intoxication. Alcoholism Clinical and Experimental Research 27(3): 485-494
Maggi, D.; Biedi, C.; Segat, D.; Barbero, D.; Panetta, D.; Cordera, R. 2002: IGF-I induces caveolin 1 tyrosine phosphorylation and translocation in the lipid rafts. Biochemical and Biophysical Research Communications 295(5): 1085-1089
Gruden, G.; Araf, S.; Zonca, S.; Burt, D.; Thomas, S.; Gnudi, L.; Viberti, G. 2003: IGF-I induces vascular endothelial growth factor in human mesangial cells via a Src-dependent mechanism. Kidney International 63(4): 1249-1255
Niesler, C.U.; Ursø, B.; Prins, J.B.; Siddle, K. 2000: IGF-i inhibits apoptosis induced by serum withdrawal, but potentiates TNF-alpha-induced apoptosis, in 3T3-L1 preadipocytes. Journal of Endocrinology 167(1): 165-174
Kooijman, R.; Coppens, A.; Hooghe-Peters, E. 2002: Igf-i inhibits spontaneous apoptosis in human granulocytes. Endocrinology 143(4): 1206-1212
Hellström, A.; Carlsson, B.ör.; Niklasson, A.; Segnestam, K.; Boguszewski, M.; de Lacerda, L.; Savage, M.; Svensson, E.; Smith, L.; Weinberger, D.; Albertsson Wikland, K.; Laron, Z. 2002: IGF-i is critical for normal vascularization of the human retina. Journal of Clinical Endocrinology and Metabolism 87(7): 3413-3416
Spangenburg, E.E. 2003: IGF-I isoforms and ageing skeletal muscle: An 'unresponsive' hypertrophy agent?. Journal of Physiology 547(Pt 1): 2
Borges, M.H.; Pinto, A.C.; DiNinno, F.B.; Camacho-Hübner, C.; Grossman, A.; Kater, C.E.; Lengyel, A.M. 1999: IGF-i levels rise and GH responses to GHRH decrease during long-term prednisone treatment in man. Journal of Endocrinological Investigation 22(1): 12-17
Kanatani, M.; Sugimoto, T.; Kano, J.; Chihara, K. 2002: IGF-i mediates the stimulatory effect of high phosphate concentration on osteoblastic cell proliferation. Journal of Cellular Physiology 190(3): 306-312
Voci, A.; Arvigo, M.; Massajoli, M.; Garrone, S.; Bottazzi, C.; Demori, I.; Gallo, G. 1999: IGF-I production by adult rat hepatocytes is stimulated by transforming growth factor-alpha and transforming growth factor-beta1. European Journal of Endocrinology 140(6): 577-582
Cheng, H.L.; Steinway, M.; Delaney, C.L.; Franke, T.F.; Feldman, E.L. 2000: IGF-I promotes Schwann cell motility and survival via activation of Akt. Molecular and Cellular Endocrinology 170(1-2): 211-215
Galvin, C.D.; Hardiman, O.; Nolan, C.M. 2003: IGF-1 receptor mediates differentiation of primary cultures of mouse skeletal myoblasts. Molecular and Cellular Endocrinology 200(1-2): 19-29
Valentinis, B.; Baserga, R. 2001: IGF-i receptor signalling in transformation and differentiation. Molecular Pathology: Mp 54(3): 133-137
Mauro, L.; Bartucci, M.; Morelli, C.; Andò, S.; Surmacz, E. 2001: IGF-i receptor-induced cell-cell adhesion of MCF-7 breast cancer cells requires the expression of junction protein ZO-1. Journal of Biological Chemistry 276(43): 39892-39897
Rice, K.M.; Garner, C.W. 1999: IGF-i regulates IRS-1 expression in 3T3-L1 adipocytes. Biochemical and Biophysical Research Communications 255(3): 614-617
Honda, J.; Manabe, Y.; Matsumura, R.; Takeuchi, S.; Takahashi, S. 2003: IGF-i regulates pro-opiomelanocortin and GH gene expression in the mouse pituitary gland. Journal of Endocrinology 178(1): 71-82
Lebl, J.; Průhová, S.; Zapletalová, J.; Pechová, M. 2001: IGF-I resistance and Turner's syndrome. Journal of Pediatric Endocrinology and Metabolism: Jpem 14(1): 37-41
Chakravarthy, M.V.; Davis, B.S.; Booth, F.W. 2000: IGF-i restores satellite cell proliferative potential in immobilized old skeletal muscle. Journal of Applied Physiology 89(4): 1365-1379
Puglianiello, A.; Germani, D.; Rossi, P.; Cianfarani, S. 2000: IGF-i stimulates chemotaxis of human neuroblasts. Involvement of type 1 IGF receptor, IGF binding proteins, phosphatidylinositol-3 kinase pathway and plasmin system. Journal of Endocrinology 165(1): 123-131
Robinson, R.M.; Akers, R.M.; Forsten, K.E. 2001: IGF-i stimulation of extracellular acidification is not linked to cell proliferation for autocrine cells. Endocrine 15(2): 205-211
Adam, C.L.; Gadd, T.S.; Findlay, P.A.; Wathes, D.C. 2000: IGF-I stimulation of luteinizing hormone secretion, IGF-binding proteins (IGFBPs) and expression of mRNAs for IGFs, IGF receptors and IGFBPs in the ovine pituitary gland. Journal of Endocrinology 166(2): 247-254
Tenoutasse, S.; Van Vliet, G.; Ledru, E.; Deal, C. 2003: IGF-I transcript levels in whole-liver tissue, in freshly isolated hepatocytes, and in cultured hepatocytes from lean and obese Zucker rats. Hormone Research 59(3): 135-141
Nilsson, A.B.; Nitescu, N.; Chen, Y.; Guron, G.S.; Marcussen, N.; Matejka, G.L.; Friberg, P. 2000: IGF-I treatment attenuates renal abnormalities induced by neonatal ACE inhibition. American Journal of Physiology. Regulatory Integrative and Comparative Physiology 279(3): R1050-R1060
Vickers, M.H.; Casey, P.J.; Champion, Z.J.; Gravance, C.G.; Breier, B.H. 1999: IGF-i treatment increases motility and improves morphology of immature spermatozoa in the GH-deficient dwarf (dw/dw) rat. Growth Hormone and Igf Research: Official Journal of the Growth Hormone Research Society and the International Igf Research Society 9(4): 236-240
Upegui-Gonzalez, L.C.; Ly, A.; Sierzega, M.; Jarocki, P.; Trojan, L.; Duc, H.T.; Pan, Y.; Shevelev, A.; Henin, D.; Anthony, D.; Nowak, W.; Popiela, T.; Trojan, J. 2001: IGF-I triple helix strategy in hepatoma treatment. Hepato-Gastroenterology 48(39): 660-666
Kajantie, E.; Dunkel, L.; Rutanen, E.-M.; Seppälä, M.; Koistinen, R.; Sarnesto, A.; Andersson, S. 2002: IGF-I, IGF binding protein (IGFBP)-3, phosphoisoforms of IGFBP-1, and postnatal growth in very low birth weight infants. Journal of Clinical Endocrinology and Metabolism 87(5): 2171-2179
Nakayama, Y.; Yamamoto, T.; Abé, S.I. 1999: IGF-I, IGF-Ii and insulin promote differentiation of spermatogonia to primary spermatocytes in organ culture of newt testes. International Journal of Developmental Biology 43(4): 343-347
Rooman, R.P.A.; De Beeck, L.Op.; Martin, M.; Van Doorn, J.; Mohan, S.; Du Caju, M.V.L. 2002: IGF-I, IGF-II, 'free' IGF-I and IGF-binding proteins-2 to -6 during high-dose oestrogen treatment in constitutionally tall girls. European Journal of Endocrinology 146(6): 823-829
Verhaeghe, J.; Coopmans, W.; van Herck, E.; van Schoubroeck, D.; Deprest, J.A.; Witters, I. 1999: IGF-I, IGF-II, IGF binding protein 1, and C-peptide in second trimester amniotic fluid are dependent on gestational age but do not predict weight at birth. Pediatric Research 46(1): 101-108
Kocamis, H.; Gahr, S.A.; Batelli, L.; Hubbs, A.F.; Killefer, J. 2002: IGF-I, IGF-II, and IGF-receptor-1 transcript and IGF-Ii protein expression in myostatin knockout mice tissues. Muscle and Nerve 26(1): 55-63
Di Luigi, L.; Guidetti, L. 2002: IGF-I, IGFBP-2, and -3: do they have a role in detecting rhGH abuse in trained men?. Medicine and Science in Sports and Exercise 34(8): 1270-1278
Sowers, M.; Scholl, T.; Grewal, J.; Chen, X.; Jannausch, M. 2001: IGF-I, osteocalcin, and bone change in pregnant normotensive and pre-eclamptic women. Journal of Clinical Endocrinology and Metabolism 86(12): 5898-5903
Seto, J.; Seto, Y.; Iino, M.; Komatsu, T.; Katagiri, K.; Hagino, A.; Aso, H.; Katoh, K.; Sasaki, Y.; Obara, Y. 2001: IGF-I-induced apoptosis in LM2d6 cultured at a low concentration of fetal bovine serum. Cell Biology International 25(9): 893-899
De Arcangelis, V.; Coletti, D.; Conti, M.; Lagarde, M.; Molinaro, M.; Adamo, S.; Nemoz, G.; Naro, F. 2003: IGF-I-induced differentiation of L6 myogenic cells requires the activity of cAMP-phosphodiesterase. Molecular Biology of the Cell 14(4): 1392-1404
Lin, D.; Boyle, D.L.; Takemoto, D.J. 2003: IGF-I-induced phosphorylation of connexin 43 by PKCgamma: regulation of gap junctions in rabbit lens epithelial cells. IOVS Investigative Ophthalmology and Visual Science 44(3): 1160-1168
Svanberg, E.; Frost, R.A.; Lang, C.H.; Isgaard, J.; Jefferson, L.S.; Kimball, S.R.; Vary, T.C. 2000: IGF-I/IGFBP-3 binary complex modulates sepsis-induced inhibition of protein synthesis in skeletal muscle. American Journal of Physiology. Endocrinology and Metabolism 279(5): E1145-E1158
Jeschke, M.G.; Barrow, R.E.; Suzuki, F.; Rai, J.; Benjamin, D.; Herndon, D.N. 2002: IGF-I/IGFBP-3 equilibrates ratios of pro- to anti-inflammatory cytokines, which are predictors for organ function in severely burned pediatric patients. Molecular Medicine 8(5): 238-246
Trojan, L.A.; Kopinski, P.; Wei, M.X.; Ly, A.; Glogowska, A.; Czarny, J.; Shevelev, A.; Przewlocki, R.; Henin, D.; Trojan, J. 2002: IGF-I: from diagnostic to triple-helix gene therapy of solid tumors. Acta Biochimica Polonica 49(4): 979-990
Gray, S.G.; Svechnikova, I.; Hartmann, W.; O'Connor, L.; Aguilar-Santelises, M.; Ekström, T.J. 2000: IGF-Ii and IL-2 act synergistically to alter HDAC1 expression following treatments with trichostatin a. Cytokine 12(7): 1104-1109
Lee, C.I.; Goldstein, O.; Han, V.K.; Tarantal, A.F. 2001: IGF-II and IGF binding protein (IGFBP-1, IGFBP-3) gene expression in fetal rhesus monkey tissues during the second and third trimesters. Pediatric Research 49(3): 379-387
Narayanan, B.A.; Re, G.G. 2001: IGF-Ii down regulation associated cell cycle arrest in colon cancer cells exposed to phenolic antioxidant ellagic acid. Anticancer Research 21(1a): 359-364
Siddals, K.W.; Westwood, M.; Gibson, J.M.; White, A. 2002: IGF-binding protein-1 inhibits IGF effects on adipocyte function: implications for insulin-like actions at the adipocyte. Journal of Endocrinology 174(2): 289-297
Butt, A.J.; Fraley, K.A.; Firth, S.M.; Baxter, R.C. 2002: IGF-binding protein-3-induced growth inhibition and apoptosis do not require cell surface binding and nuclear translocation in human breast cancer cells. Endocrinology 143(7): 2693-2699
Smith, E.P.; Kamyar, A.; Niu, W.; Wang, J.; Cercek, B.; Chernausek, S.D.; Fagin, J.A. 2001: IGF-binding protein-4 expression and IGF-binding protein-4 protease activity are regulated coordinately in smooth muscle during postnatal development and after vascular injury. Endocrinology 142(10): 4420-4427
Zhou, R.; Diehl, D.; Hoeflich, A.; Lahm, H.; Wolf, E. 2003: IGF-binding protein-4: biochemical characteristics and functional consequences. Journal of Endocrinology 178(2): 177-193
Schneider, M.R.; Wolf, E.; Hoeflich, A.; Lahm, H. 2002: IGF-binding protein-5: flexible player in the IGF system and effector on its own. Journal of Endocrinology 172(3): 423-440
Fukushima, K.; Komatsu, H.; Matsumoto, M.; Kobayashi, H.; Tsukimori, K.; Satoh, S.; Nakano, H. 2002: IGF-related proteins at birth in a case of antenatally diagnosed Silver-Russell syndrome. Pediatric Research 51(3): 323-327
Peretz, S.; Kim, C.; Rockwell, S.; Baserga, R.; Glazer, P.M. 2002: IGF1 receptor expression protects against microenvironmental stress found in the solid tumor. Radiation Research 158(2): 174-180
Butt, A.J.; Williams, A.C. 2001: IGFBP-3 and apoptosis--a license to kill?. Apoptosis: An International Journal on Programmed Cell Death 6(3): 199-205
Katsaros, D.; Yu, H.; Levesque, M.A.; Danese, S.; Genta, F.; Richiardi, G.; Fracchioli, S.; Khosravi, M.J.; Diamandi, A.; Gordini, G.; Diamandis, E.P.; Massobrio, M. 2001: IGFBP-3 in epithelial ovarian carcinoma and its association with clinico-pathological features and patient survival. European Journal of Cancer 37(4): 478-485
Cohen, P.; Rajah, R.; Rosenbloom, J.; Herrick, D.J. 2000: IGFBP-3 mediates TGF-beta1-induced cell growth in human airway smooth muscle cells. American Journal of Physiology. Lung Cellular and Molecular Physiology 278(3): L545-L551
Grimberg, A.; Liu, B.; Bannerman, P.; El-Deiry, W.S.; Cohen, P. 2002: IGFBP-3 mediates p53-induced apoptosis during serum starvation. International Journal of Oncology 21(2): 327-335